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Abstract 
Iron deficiency is the most common nutritional deficiency worldwide, affecting 
over 2 billion people, especially women and children.  Populations consuming maize as a 
staple food are particularly prone to iron deficiency because of the low iron 
bioavailability (FeBA).  The overall objective of this three-part study is to enhance FeBA 
in foods made of maize through novel fortification techniques, processing modifications, 
and genetic modifications.   
The first study focused on the fortification of plant heme iron to improve FeBA in 
tortillas.  Plants, particularly soy roots can produce heme iron as part of nitrogen fixation.  
Our objective was to test the effectiveness of soy root nodule (SRN) and purified soy 
hemoglobin (LHb) for FeBA using the in vitro Caco-2 cell model compared to bovine 
hemoglobin (BHb), and ferrous sulfate (FeSO4).  When iron sources were tested alone, 
the FeBA values of LHb and BHb were 19% (P > 0.05) and 113% (P < 0.001) higher 
than FeSO4, respectively. However, when iron sources were used for fortification of 
maize tortillas (50 ppm), LHb and BHb showed similar FeBA, being 27% (P < 0.05) and 
33% (P < 0.05) higher than FeSO4.  Our data suggest that heme iron from plants may be a 
novel value-added food fortificant with enhanced FeBA. 
The second study evaluated the effects of maize processing on FeBA, with the 
intent to modify processing to enhance FeBA.  Representative maize processing 
techniques were used: heating (porridge), fermentation (ogi), nixtamalization (tortillas), 
and decortication (arepas).  The phytate content of maize products was significantly 
reduced by decortication (25.6%, p = 0.003) and nixtamalization (15%, p = 0.03), and 
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iron content was reduced by decortication (29.1%, p = 0.002). The relative bioavailability 
(RBA, compared to 100% FeBA of porridge with FeSO4) of ogi was significantly higher 
than that of all other products when fortified with FeSO4 (p < 0.001) or reduced iron (p < 
0.001). Addition of lactic acid (6 mg/g of maize) significantly increased iron solubility 
and increased FeBA by about 2-fold (p < 0.01), especially in tortillas. Consumer panel 
results showed that lactic acid addition did not affect the organoleptic characteristics of 
tortillas and arepas (p = 0.166 and 0.831, respectively). These results suggest that 
fermentation, or the addition of lactic acid to unfermented products, may improve FeBA 
of maize products.  Lactic acid addition may be more feasible than using highly 
bioavailable but expensive fortificants.  
The last study involved genetic modification by overexpression of Zea mays 
hemoglobin (ZmHb) in maize endosperm tissue.  A first vector was developed by cloning 
a high expression 27γ zein promoter from maize, and recombining it with a ZmHb gene 
fused to Green Fluorescent Protein (GFP), and nos terminator.  Constructs with further 
modifications based on this first vector model were also produced: one without GFP and 
the other using 27γ zein terminator.  Maize callus was bombarded with the first vector, 
regenerated to plants which produced first generation (F1) seed.  High GFP expressing 
seed, as determined by excitation fluorescence spectrophotometry, was shown to have 
4.2-4.9 ug ZmHb/g maize based on immunoassay with ZmHb antibody.  Heme pyrolle 
incorporation into the protein was shown by iron catalysed chemilluminescence.  
Preliminary studies on two high GFP expressing lines show that FeBA of ZmHb 
enhanced maize, determined by the Caco-2 cell assay, was 68–125% higher than the 
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untransformed inbred maize variety, HiII (p < 0.01).  Based on estimates from these 
assays, delivery of 1.6-2.5 µg heme iron per 100g serving of maize is possible.  Our 
preliminary results in developing transgenic and intragenic maize suggest that 
overexpression of ZmHb in endosperm is feasible and may significantly enhance FeBA 
of maize by adding highly bioavailable heme iron.  
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General Introduction 
It is well known in the nutrition field that iron deficiency is the most prevalent 
nutritional deficiency worldwide, affecting over 2 billion people (WHO, 2007).  And 
many strategies for alleviation of iron deficiency exist, including supplementation, 
fortification, and dietary diversification.  Still, rates of iron deficiency in populations are 
not declining as rapidly as one would hope, at less than 0.5% per year (Micronutrient 
Initiative, 2006).  New strategies must be developed if iron deficiency rates are going to 
decrease at a rate that makes a significant impact on populations.   
Maize is the staple food of many populations that are experiencing the most 
severe iron deficiency.  In Central America and many parts of Sub Saharan Africa maize 
can comprise greater than 1500 kcal per day in the diet (FAOSTAT, 2004).  With maize 
playing such an integral part of the diet, the micronutrient quality must be well 
understood.  Maize has a very high level of phytate, which acts as an inhibitor of iron 
absorption, leaving a very low percentage of total iron absorbed.  Attempts at iron 
fortification in foods made of maize have been only minimally successful, because the 
food matrix effects of maize are far too prominent.  But perhaps it is the food matrix 
effects of maize foods that have been under-looked in nutrition studies evaluating 
bioavailability of maize fortificants.  More effort is needed to evaluate how foods made 
of maize affect the absorption of iron, to define better practices in processing and 
fortification. 
Hemoglobin has long been known to be a highly bioavailable iron source.  The 
primary strategy for alleviation of iron deficiency through the diet is to eat more heme 
iron.  Incorporation of meat into the diet, however, is often economically impossible, or 
 2
culturally inappropriate.  It is now known that plants produce hemoglobin proteins with 
similar structural characteristics to animal hemoglobins.  The use of plant sourced 
hemoglobins has not been evaluated in a nutritional context.  Either using naturally 
derived hemoglobins from plants that produce large quantities, such as soy root nodules, 
or using biotechnology based strategies to overexpress hemoglobin proteins in seed 
tissues of plants, such as maize, have not been explored. 
 
Rationale 
Given the massive impact of iron deficiency on the world, new strategies for 
alleviating iron deficiency are warranted.  Maize, as the staple grain of populations 
seriously affected by iron deficiency, requires a particular level of attention in this regard.   
This dissertation focuses on three strategies to improve iron bioavailability in maize: 
fortification, processing and biotechnology.  With these strategies, this study shows proof 
of concept for new technology targeted at enhancing nutritional quality of iron. 
 
Research Questions 
This dissertation was designed to address the following gaps in understanding of 
iron bioavailability in maize: can understanding the food matrix effects of maize in its 
diverse food forms help us find better ways of processing and fortifying maize?   Can 
hemoglobins from plants be a novel means of increasing bioavailable iron?  And lastly, 
can we use biotechnology based approaches to use maize genetics to enhance iron 
bioavailability?  
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Organization of the study 
This dissertation is divided into three main studies.  The first study, in part 3, is 
entitled, “Iron Bioavailability of Hemoglobin from Soy Root Nodules Using a Caco-2 
Cell Culture Model”.  This study is the first to evaluate the bioavailability of plant based 
hemoglobin proteins, to compare their bioavailability to animal sourced hemoglobin.  
This study is also the first to apply plant derived hemoglobins as a food fortificant.  This 
study has been published in the Journal of Agricultural and Food Chemistry in 2006.   
The second study, “Fermentation and lactic acid addition enhance iron 
bioavailability of maize” is a comprehensive study evaluating the effects of the 
predominant maize processing techniques on iron bioavailability.  It also used a 
retrospective/prospective approach to processing, in that once the effects of typical 
processing were understood, the maize products were reformulated, incorporating the 
factors known to enhance bioavailiability, in this case acidification with lactic acid.  With 
this second reformulation, much greater impacts on improving iron bioavailability were 
seen.  This study was published in the Journal of Agricultural and Food Chemistry in 
2007. 
The last study, entitled “Overexpression of Zea mays hemoglobin in maize 
endosperm tissue can increase iron bioavailability” is the first study involving 
overexpression of hemoglobins for a nutritional purpose.  The biotechnology based 
approach described in the study is novel for the use of a reporter gene, green fluorescent 
protein, in the first round of studies.  This study is a long term research project, which 
will be completed in several years.  The novel strategy of using intragenic transformation, 
described in this case as the use of only maize genes in recombination, is a very exciting 
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development.  Use of only maize genetics to enhance iron bioavailability would be a very 
new strategy in the realm of biofortification.  This study has been prepared with the 
intention to submit to the Journal of Nutrition upon evaluation and analysis of the F2 
seed, a more robust data set.  This is to be conducted in the Autumn of 2007. 
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Literature Review 
 
Introduction 
Iron deficiency is the world’s most prevalent nutritional deficiency, and perhaps is 
the nutritional deficiency which has been the most challenging to overcome.  Iron has a 
complex absorption pathway confounded by extraneous factors in the diet.  The challenge 
with bioavailability is one of the main reasons that iron deficiency remains as the most 
prevalent nutritional deficiency worldwide. 
Globally, most iron is consumed from staple crops, plant-based foods which have 
very low bioavailability.  Nutritional interventions to increase iron content in foods by 
fortification are the most cost effective method of delivering iron to populations but have 
been challenged by the complexities of food chemistry and food matrix effects.  
Addressing these challenges, and reducing iron deficiency could improve the health, 
wellbeing and productivity of billions of people worldwide.   
 
Iron Deficiency 
The Global Prevalence of Iron Deficiency 
Based on current estimates, iron deficiency (ID), and associated iron deficiency 
anemia (IDA) affects over 2 billion people worldwide (WHO, 2007; Micronutrient 
Initiative, 2006).  It has been suggested that 40 to 60% of infants between 6 and 24 
months of age globally have reduced neural development, that 600,000 women die 
annually during childbirth, and up to 2% of GDP in developing countries is lost because 
of iron deficiency (Micronutrient Initiative, 2006).     
 6
Because of the global significance of iron deficiency, goals for iron deficiency 
alleviation have been set by international organizations.  In 1990, the World Summit for 
Children declared the goal of “virtual elimination of iodine and vitamin A deficiency and 
a reduction of the prevalence of iron-deficiency anaemia in women by one third” by the 
year 2000 (UNICEF, 1990).  This goal was continued in 1992 at the International 
Conference on Nutrition hosted by FAO and WHO, with the consensus “to reduce 
substantially . . . other important micronutrient deficiencies, including iron.”  (FAO and 
WHO, 1992).  The challenge that was encountered with this approach was that many 
country-based strategies focused on a single intervention, rather than accounting for and 
rectifying the diverse causes of iron deficiency.  As such, there was little change in iron 
deficiency rates during this ten-year time, with most global regions seeing reductions in 
iron deficiency in women (both pregnant and not) of less than 0.5% per year 
(Micronutrient Initiative, 2002).  
At the 27th General Assembly Special Session Declaration, ‘‘A World Fit for 
Children’’ in 2002, there was a slight change in strategy, to incorporate the concept 
of a diversified strategic mission to “reduce by one third the prevalence of anaemia, 
including iron deficiency, by 2010; and accelerate progress towards reduction of other 
micronutrient deficiencies, through dietary diversification, food fortification and 
supplementation.” (UNICEF, 2002).  This slight change in the goal specifically noted the 
importance of diverse strategies to alleviate iron and other micronutrient deficiencies.  
Despite setting and working towards goals, only minor progress has been made to date. 
Iron deficiency and IDA are health issues that are correlated to diet quality and 
public health, and these are usually tied to economic and social development (Horton, 
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2006) and in particular have the most devastating impact on women, infants and children 
(Darton-Hill et al, 2005).  The scope of this research is not able to address the 
socioeconomic challenges of micronutrient deficiency, but strongly identifies with the 
principle that through socioeconomic development, nutrition and wellbeing can be 
improved.   
 
Importance of Iron 
Iron is essential for growth and development because of its importance in a wide 
variety of biochemical processes involved in maintaining cellular function.  These 
include electron transport (cytochromes, iron-sulfur proteins), handling of molecular 
oxygen (peroxidase, catalase), oxygen transport and storage (hemoglobin and myoglobin, 
respectively), porphyrin metabolism, collagen synthesis, lymphocyte and granulocyte 
function, and neurotransmitter anabolism and catabolism (Cammack et al. 1990, Pollitt 
and Leibel 1976). 
Body iron commonly exists in two oxidative states, the divalent ferrous and the 
trivalent ferric.  Because of its oxidative states, heme iron functions in the respiratory 
cascade as an electron carrier as part of cytochromes in mitochondria and as a ligand for 
O2 and CO2 transport between tissues in the form of hemoglobin and myoglobin.  Iron is 
also contained in myoglobin, which stores oxygen in the tissues.  Aerobic metabolism 
requires iron in the Kreb’s Cycle as a cofactor of some enzymes, such as aconitase and 
succinate dehydrogenase.  The nonheme iron present in these enzymes is tightly bound to 
the sulfur atoms of cysteine residues.  The complexes are often referred to as “iron-sulfur 
proteins” or “iron-sulfur clusters” if more than one such complex exists.  Other nonheme 
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iron-containing enzymes are ribonucleotide reductase, needed for deoxyribonucleic acid 
(DNA) synthesis, xanthine dehydrogenase, necessary for catabolism of the purine ring, 
and NADH dehydrogenase and coenzyme-Q reductase, required in the respiratory 
cascade (Brody 1994). 
Iron deficiency in infants and children has been associated with poor cognitive 
and behavioral development and these consequences are reviewed extensively (McCann 
and Ames, 2007).  There still remains some controversy over the nature of a true causal 
relationship between iron deficiency and cognitive development since there are other 
confounding factors such as socioeconomic and nutritional factors.  It has been suggested 
for example that iron deficient children typically belong to lower income groups, and 
may not have the stimulation and maternal care that is received by children in higher 
income settings (Grantham-McGregor and Ani, 2001).  It is also suggested that iron 
deficiency due to diet is rarely seen alone and multi-nutrient deficiencies may be 
aggravating the proper development of cognition (Grantham-McGregor and Ani, 2001).  
More recent work however has suggested role of iron in neural tissue development and 
that iron deficiency in infancy affects neurometabolism, myelination, and 
neurotransmitter function (Lozoff et al, 2006). 
Iron deficiency anemia has also been associated with fatigue and reduced work 
output due to reduced aerobic capacity and oxygen transport (Haas and Brownlie, 2001,).  
The effect of iron on fatigue and output has been measured in terms of reduced aerobic 
capacity (Brownlie et al, 2002), reduced muscle endurance (Brutsaert et al, 2003), and 
lower economic productivity (Gopaldas and Gujral, 2003).   
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It is also suggested that iron deficiency and in particular severe anemia 
(Hemoglobin (Hb) < 7.0g/dL) is a significant risk factor for increased morbidity and 
mortality during childbirth.  The assumption is that the etiology comes from the 
combination of increasing blood volume during pregnancy, blood losses during 
childbirth, coupled with the high potential for uterine hemorrhaging in the early antenatal 
period.  The epidemiological or longitudinal evidence is seriously lacking in this regard, 
however it is strongly understood that improved iron status mitigates much of this burden 
(Viteri, 1994; Rush, 2000) 
The positive effects of iron supplementation on weight for age and weight for 
height are well documented in severely iron deficient children, but not in subclinical iron 
deficiency (Sachdev et al, 2006) suggesting the importance of iron in growth and 
development .    
 
Iron Requirements 
 When considering iron deficiency, one must take into account iron intake and 
losses, and their equilibrium.  Metabolic iron need is based on the physiological state 
such as pregnancy and growth.  When iron losses or needs exceed the intake, iron 
deficiency occurs.  Iron losses occur in menstruation, from infection (as in the case of 
intestinal parasites, or malaria), or from other trauma causing low level chronic or acute 
massive blood losses (for example childbirth, or hemorrhaging).  The amount of total iron 
in the body varies between 2 and 4 g, and varies based on size, age, gender and 
physiological state.  Total iron in the body is distributed in several compartments (Figure 
2.1.).  Most iron in the body (65%) is present in the erythrocytes, with a significantly 
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lesser proportion in circulating iron bound to transferrin (<1%).  Tissue iron, in the form 
of myoglobin forms the largest store (20%) however a small proportion is present (2%) in 
tissues as enzymes such as aconitase or cytochromes.  The body’s store of iron is highly 
conserved (Fairbanks, 1998). 
Iron losses in healthy individuals are typically 1 mg in men and 1.5 mg in women 
daily (Cook et al, 1992).  These losses come from desquamation of the intestinal mucosa, 
hemoglobin in fecal matter, bile secretions, and losses of epithelial cells (Haurani and 
Marcolina, 1994).  Menstruation is a significant source of iron loss, and accounts for the 
large variation of iron requirements between men and women of childbearing age 
(Fairbanks, 1998).   
The amount of dietary iron that needs to be absorbed on a daily basis ranges from 
1-1.5 mg/d to account for the obligatory losses of iron described above.  Current 
recommendations for iron allowance are for 8 mg/d for males and postmenopausal 
women, and 18 mg/d for women of childbearing age.  This is based on an assumption that 
10% of iron is absorbed from the diet.  How much iron absorbed is dependant on three 
factors: the total iron content, the bioavailability, and the iron status of the individual.  
The iron content of diets in most developing countries is low to moderate, however the 
low bioavailability of the predominantly plant based diet trumps the iron content, 
rendering iron unavailable for absorption. 
 
Dietary Iron Absorption 
Dietary iron exists in heme and nonheme forms, which form the two pools in the 
gut: nonheme and heme iron.  Heme iron is derived from heme proteins, in particular 
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hemoglobin and myoglobin from animal sources.  Plants are also capable of producing 
heme iron in very low concentrations.  Heme iron is a highly bioavailable iron form, as 
the heme pyrrole acts as a protective clathrate structure, preventing interference from iron 
chelators, such as polyphenols or phytate (Andrews, 2005).  Secondly, heme iron is 
absorbed by a unique pathway, different from nonheme iron.  The pathways of iron 
absorption are described further in this paper.  Heme iron contributes a minor fraction of 
the total iron in the diet, 10-15%, however because of the bioavailability, it accounts for 
approximately one third of the total iron absorbed (Hallberg and Rossander, 1982).  
Roughly 60-75% of iron in meat, fish and poultry is heme iron, which is approximately 
30% available (Monsen, 1988).  Extensive work has been done characterizing animal 
heme iron, however only one study reported in this dissertation shows that plant 
hemoglobin has similar bioavailability characteristics to heme iron from animal sources 
(Proulx and Reddy, 2006).   
Nonheme iron is the predominant iron form in plant foods and makes up about 
25% of the iron from animal foods.  Nonheme iron is liberated from the food matrix, and 
ionized during gastric digestion and absorbed predominantly in the proximal duodenum 
(Dunn et al, 2007).  In staple grains, absorption of iron tends to be very low, ranging from 
1-7% (Monsen, 1988).   Nonheme iron interacts with dietary inhibitors, such as phytate 
and polyphenols, or dietary enhancers such as ascorbic acid or the putatative polypeptide 
based “Meat Factor” (Zijp et al, 2000; Swain at al, 2002).  As nonheme iron is absorbed 
into the intestinal epithelium by a transporter that is also responsible for transport of 
calcium and other divalent cations, there is competitive transport for iron with high 
concentration of divalent cations (Garrick et al, 2003).  Ascorbic acid acts as an iron 
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chelator with high stability under a variety of pH conditions which enhances iron 
solubility (Teucher et al, 2004).  Phytic acid acts as a potent chelator of iron and other 
cations because of its high negative charge density from multiple phosphate groups (Zhou 
and Erdman, 1995).  Polyphenols and tannins similarly act to chelate iron through 
binding with negatively charged groups (Scalbert et al, 2005).   
 
Iron Uptake and Utilization 
Iron absorption has a complex uptake pathway, based on the type of iron being 
transported, as shown in Figure 2.2.   Ferric iron is reduced to ferrous form by duodenal 
cytochrome b (Dcytb) (McKie et al, 2001), or another uncharacterized ferric reductase 
(Gunshin et al, 2005).  Ferrous iron is transported through the apical membrane into the 
enterocyte by a divalent metal transporter 1 (DMT1), in a saturable and competitive 
manner.  DMT1 is also responsible for proton transport, and transport of other metal 
cations, including zinc, calcium and magnesium (Gunshin et al, 1997).  Heme iron is 
postulated to be transported into the enterocyte by heme carrier protein 1 (HCP1) 
(Shayeghi et al, 2005), however current knowledge of the transport mechanism is being 
debated, as it is postulated that HCP1 is not a heme transporter, rather a folate transporter 
(Qui et al, 2006).  HCP1, based on current understanding is internalized by receptor-
mediated endocytosis, followed by heme degradation by heme oxygenase 1 at the surface 
of the endoplasmic reticulum, liberating ferrous iron into the enterocytes (Shayeghi et al, 
2005).  The labile iron pool (LIP) is postulated to not be “free iron” rather iron in 
chaperone proteins, for example ferritin (Theil, 2003), or low molecular weight peptide 
chelates thereby limiting Fenton reaction production of free radicals.  Iron is transported 
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through the basolateral membrane by ferroportin 1 (FPN1) (Donovan et al, 2000), with 
oxidation to ferric form by hephastin (Hp) followed by transport within the blood by 
transferrin (Vulpe et al, 1999).   It is understood that under normal physiological 
conditions, FPN1 is negatively regulated by hepcidin.  Hepcidin, an iron regulatory 
hormone expressed iron replete conditions, binds with FPN1, causing its internalization 
and degradation (Fraenkel et al, 2005).  As only FPN1 has been implicated in iron 
transport to the circulation, it is postulated that FPN1 is the transporter implicated in 
limiting iron uptake during iron replete status (Donovan et al, 2000).  Iron is transported 
in the serum by serum transferrin (Tf), and taken up by the cells by transferrin receptor 
(TfR) binding to the iron bound transferrin, then internalizing Tf by receptor mediated 
endocytosis. When cellular need for iron increases, TfR expression is upregulated, hence 
increasing iron uptake (Figure 2.3).  It is suggested that TfR may act as a sensor of 
transferrin bound iron, influencing expression of hepcidin, a regulatory hormone 
affecting the FPN1 mediated release of iron from the enterocytes, macrophages and 
hepatocytes (Fleming and Bacon, 2005). 
Based on the understanding of iron metabolism, the measures of iron status were 
developed.  A wide variety of iron status biomarkers have been evaluated for ability to 
reflect stages of iron deficiency.  Similar to the complexity of iron absorption, iron status 
measures are complex.  Infections, inflammations and other nutrient deficiencies affect 
iron status, and as such a battery of tests are needed for specific iron assessment.  The 
current iron status biomarkers used in clinical evaluation are listed in Table 2.1.  
 
Alleviating iron deficiency 
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Improvement of iron status is currently based on three primary strategies, food 
fortification, supplementation, and dietary diversification.  These strategies have recently 
been expanded to incorporate biofortification. 
The success of all schemes to alleviate iron deficiency is evaluated by 
characterizing a variety of factors including the bioavailability, the efficacy and 
effectiveness of the food or supplement for alleviating and attenuating deficiency in 
affected individuals and populations.  This also includes evaluating the acceptability of 
the intervention in terms of nutrient stability, cost, and organoleptic influence.  
 
Assessment of Iron Bioavailability 
Bioavailability is the relative measure of how well a nutrient is absorbed by the 
human body and becomes available for metabolic use.  It is measured either indirectly 
using in vitro or animal studies, or directly in humans.  In vitro methods, including 
solubility assays, and cell culture methods are commonly used as screening techniques 
for bioavailability.  It is difficult to directly extrapolate the results from in vitro 
bioavailability measurements to human absorption and nutrient utilization, although they 
are efficient and cost effective methods of screening relative bioavailability.  Animals 
may be more physiologically similar to humans than in vitro models for assessing 
bioavailability; however, for many nutrients, biological need differs from animal to 
human, or utilization differs due to variation in absorptive or synthetic pathways.  Animal 
studies, like in vitro studies, are most practical as screening methods for relative 
bioavailability of fortificants, and in many circumstances may not be appropriate.  In the 
case of rats, dietary factors differ in their ability to enhance iron bioavailability (Reddy 
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and Cook, 1991).  Most effectively, human bioavailability studies are used to evaluate 
bioavailability and efficacy of fortification schemes.   
Bioavailability is typically assessed by measuring absorption of radio or stable 
isotopes of nutrients by measuring change in metabolite synthesis, or excretion.  
Bioavailability is a useful tool in developing fortification schemes, in that it is predictive 
of the potential efficacy, and can approximate what dose level one would receive with 
long term consumption.  Most studies conducted to date to evaluate fortification schemes 
have been bioavailability studies either in vitro, or using animals or humans.   
Bioavailability studies are inherently limited in their capacity to evaluate how a 
fortified food would improve general population health, as is determined in efficacy and 
effectiveness studies.  Human bioavailability studies are usually conducted on normal, 
healthy adults, which in the case of iron may not accurately correlate to absorption rates 
in iron deficient subjects, as iron absorption is upregulated in iron deficiency (Fairbanks, 
1998). 
The use of cell culture models for iron bioavailability assessment has greatly 
increased in the past fifteen years.  The Caco-2 cell line is derived from a human colonic 
adenocarcinoma which spontaneously differentiates in cell culture to form a polarized 
epithelial monolayer with many of the characteristics of enterocytes (Pinto et al, 1983).  
This cell line has been shown to correlate reasonably well with human bioavailability 
models (Au and Reddy, 2000) at a fraction of the cost and time commitment.  Recent 
work in the characterization of heme iron uptake pathways using Caco-2 cells suggests 
that beyond the well described application for non-heme iron bioavailability, this cell line 
may also be applicable to heme iron bioavailability (Uc et al, 2004; Follett et al, 2002).  
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The use of radioisotope based uptake, or ferritin as an index of bioavailability is well 
established (Au and Reddy, 2000; Glahn et al, 1998).   
 
Iron Intervention Trials 
In efficacy studies, iron fortified food or supplements are given for several 
months to a targeted group of individuals who exhibit iron deficiency, and changes in 
iron status are followed over time.   The study design includes randomization of 
treatments, double-blinding to the treatment received, and using a placebo to control for 
effects unrelated to treatment factors.  By controlling the food and nutrient intake of 
subjects, the inherent variability that a free living subject would experience in their food 
consumption is not observed.  Researchers can however, through use of appropriate 
biomarkers, make estimates on nutrient bioavailability, for example using serum ferritin 
and transferrin receptor (Cook et al, 2003), and can show clinical evidence of alleviation 
of nutrient deficiency through administration of fortified foods or supplements. 
Effectiveness studies are the final determinant of an intervention’s performance, 
through delivery of a fortified food or supplement in a free living population.  In an 
effectiveness study compliance, economic limitations, and factors affecting purchasing, 
distribution, consumption, absorption, and utilization of the nutrients can be under 
scrutiny within the context of alleviating nutrient deficiency.  Effectiveness studies 
introduce fortified food or supplement into a population through the usual domestic or 
institutional channels, with the food or supplement subjected to variable consumption 
patterns, environmental and home preparation variables.  Efficacy is defined as “the 
extent to which a specific intervention, procedure, regimen, or service produces a 
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beneficial effect under ideal conditions”, whereas effectiveness has to do with the extent 
to which the same “specific intervention, procedure, regimen or services when deployed 
in the field does what it is intended to do for a defined population” (Last, 1998).  In many 
circumstances, effectiveness studies carry the most credible weight for justifying the 
implementation of programs to policy makers.  Unfortunately, effectiveness and efficacy 
studies are very expensive, and as such these studies in maize fortification schemes are 
rare.   
 
Intervention Strategies to Alleviate Iron Deficiency 
Supplementation is a useful mechanism for quickly alleviating iron deficiency 
through delivery of a controlled quantity of iron in a pharmacological format.  Because of 
the high dose of iron given in supplementation, compliance may be low due to the side 
effects of gastric discomfort.  In addition, supplementation requires an intensive public 
health system to provide proper availability and distribution, although it is typically a 
short term intervention (e.g. several months during pregnancy, or to alleviate clinical iron 
deficiency anemia).  Recommendations for universal supplementation in iron replete 
women and children under the age of 5 may be causing unnecessary oxidative stress, 
while iron supplementation in protein energy malnutrition may increase morbidity, and in 
certain infections such as malaria increase mortality (Shumann et al, 2007).   
Improvement of dietary diversity is a long term strategy that can effectively 
improve not only iron status, but most nutrient statuses through encouraging consumption 
of nutrient dense foods.  The challenge of dietary diversification is that it requires a very 
strong political, social, and economic will within national and community level 
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organizations.  Changing peoples’ diets to improve nutritional quality is a long-term 
challenge that requires a strong educational component to show the potential benefits to 
the individual and the population.  Since this strategy relies on natural food products, it 
has greatest opportunity for self sustainability.  Dietary diversification is prone to failure 
during economic crisis, changes in agronomic conditions such as drought, flooding or 
introduction of plant or animal diseases, or changes in industrial or economic 
development, as in changing from self-sustenance to a trade oriented food supply 
(Tontisirin et al, 2002).    
Dietary diversification can also be expanded to incorporate modifications in how 
foods are processed prior to incorporation into the diet.  A moderate body of work is 
available suggesting how basic household or industrial processing can affect iron 
bioavailability in foods made of maize, in particular focusing on phytate reduction (Hotz 
and Gibson, 2007). 
Fortification has traditionally been termed as the addition of nutrients in low 
amounts to industrially prepared staple foods targeted to the vulnerable population.  
Recent innovations have transitioned the concept of fortification into a broader context, 
including household fortification using self-administered “Sprinkles” mixed into 
household prepared meals (Zlotkin et al, 2004).  It also includes co-fortification with non-
nutritive components such as EDTA to enhance bioavailability (Hettiarachchi et al, 
2004), and biofortification (Hotz and McClafferty, 2007).  Industrial fortification uses 
commercial food processing and distribution channels for delivery of a nutrient in a 
staple food that is consumed in a self-limiting manner.  Household-level fortification uses 
nutrient premixes formulated to the needs of the regional population and added to home 
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prepared foods.  Biofortification is the process where nutrients are added by biological 
means to staple foods (mostly grains and starchy plant foods), through traditional or 
molecular crop breeding.  Bioavailability enhancement can include addition of non-
nutrients to enhance bioavailability (eg EDTA addition), or processing is modified to 
change the bioavailability characteristics (eg phytate reduction).   
There no consensus regarding best practices in fortification, especially in maize.  
This lack of consensus is based on the lack of food matrix characterization and its effect 
on fortification.  Given that there are few effectiveness studies, there is only minimal 
political will to legislate mandatory fortification or provide incentives for voluntary 
fortification.  A strong advocacy campaign has been conducted by various non-
governmental organizations in the attempts to promote the international nutritional goals 
outlined at the beginning of this review, especially alleviation of iron deficiency.   
 
Iron fortification of maize food products 
Of all the nutrients used for maize fortification, none provides as much challenge 
for success as iron.  For this reason, a substantial proportion of the literature on 
bioavailability and maize deals with iron.  The challenge of iron fortification, as in many 
fortification interventions, is the optimization of the fortification scheme in terms of 
bioavailability, acceptability and cost (Hurrell, 2002).  Iron compounds have a variety of 
issues in regards to all of the above criteria, and particularly with respect to 
bioavailability in that it is highly variable based on the solubility of the iron itself, and is 
compounded by interactions with fiber, phytate and proteins in the food matrix, all of 
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which inhibit the absorption of the iron.  On the other hand, food matrix interactions may 
enhance iron availability through chelating agents, protein binding, and pH effects.   
 
Food matrix interactions 
A number of factors in the food matrix impact iron in maize foods, including 
fiber, zein protein, and pH.  A study was conducted to evaluate the food matrix 
interactions of maize tortillas on iron solubility from ferrous and ferric iron.  In this 
study, it was found that increased fiber or zein protein (the dominant maize protein) 
content in tortillas significantly reduced ferrous iron solubility at pH 6 or higher, but 
increased ferrous solubility at pH < 5.  Ferric iron solubility was markedly reduced 
between pH 4.5 and pH 7.5, and similarly reduced with increasing zein and fiber content 
(Reinhold, et al, 1984).   
Fortification iron has a potential negative effect on organoleptic quality of maize 
products, in that soluble forms of iron can cause oxidative rancidity.  As part of an 
accelerated storage study, fortification with either 40mg iron/lb (88ppm), or 200mg 
iron/lb (441ppm) as ferrous sulfate caused rancid odour after 28 days storage at 49°C in 
coarse maize grits, fine grits, and degerminated cornmeal.  Reduced iron caused a 
subnormal odour in both fine and coarse grits under the same conditions.  Flavor scores 
were lower in the products with odour defects.  Reduced iron, which is known to have 
minimal solubility, had only minimal changes in odour and flavor after 28 days and 56 
days storage (Anderson, et al., 1976).  Significant changes in nutrient composition occur 
during the physical transformation of maize to tortillas. The grinding implements used for 
tortilla manufacture have shown to increase iron and zinc content, in particular the 
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combined use of traditional mortars and pestles and hand powered disc mills (Krause, et 
al., 1992; Krause, et al., 1993). 
 
Bioavailability of iron fortification 
A study assessing the intrinsic iron bioavailability of various traditional Latin 
American diets indicated that there is significant inhibition of iron absorption from many 
traditional foods - especially from maize based diets, and suggested that fortification 
would be a suitable method for overcoming the minimal iron absorbed from the diet 
(Acosta, et al. 1984).  A similar study, examining the intrinsic iron of Latin American 
diets indicated that a diet of tortillas and beans had a significantly lower iron 
bioavailability than a diet to which a source of ascorbate (orange juice) and animal 
protein (eggs) had been added.  The iron absorption in the maize tortilla based diet was 
7.6% as compared to 21.3% in the enhanced diet (Maisterrena, et al. 1973). A study 
looking at the bioavailability of iron from traditional maize foods of Benin found that 
absorption rates were very low, ranging from 1.2% to 3.2% in maize-based meals 
evaluated by extrinsic radiolabeling method (Galan et al, 1990).  
Maize foods have been studied extensively for appropriateness of iron fortificants, 
and the summary of some major studies can be found in Table 2.2.  In the fortification 
bioavailability studies described in Table 2.2, a variety of food products were 
characterized, including maize porridges, nixtamalized tortillas, and maize based 
complementary foods.  This information is summarized in Table 2.3.  It is challenging to 
make best practices recommendations based on the diversity of products listed, especially 
without descriptions of processing and composition information.   
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Ferrous sulphate, because of its exceptionally high solubility, tends to have high 
bioavailability in maize foods; however, as described above, ferrous sulphate can impart 
negative organoleptic qualities to maize foods, especially dry flours that are stored for 
extended periods.  Ferrous fumarate and ferric EDTA have very good bioavailability in 
maize foods because of their high solubility, and in the case of ferrous EDTA minimized 
inhibition from dietary factors, however they have higher monetary cost.  The 
bioavailability of less soluble iron compounds, for example reduced iron, is very difficult 
to assess because of the difficulties of manufacturing radiolabeled iron.  Attempts have 
been made to assess the true bioavailability without intrinsic tag labeling, but have shown 
minimal success (Hurrell, et al. 2002a).  Reduced iron, the least expensive type of iron 
fortificant, has marginal bioavailability in humans (Walter, et al. 2004).    
Beyond bioavailability, the use of fortificants is strongly influenced by cost 
effectiveness.  A theoretical cost analysis of nixtamalized corn flour fortification with 
iron is summarized in Table 2.4, with ferrous sulphate not included because of its poor 
stability in maize.   
Ferrous fumarate has been designated the most appropriate iron fortificant for 
maize foods by a number of groups, including the Venezuelan government.  Iron 
fortification in Venezuela with 20 or 50 mg Fe as ferrous fumarate per kilogram flour in 
precooked yellow and white maize flours, along with a vitamin mix resulted in a 
significant decrease in iron deficiency rates, particularly in low socioeconomic groups.  
The percentage of subjects with low serum ferritin concentration decreased from 37% to 
15% in children 7, 11 or 15 y in Caracas, Venezuela, over a 1 year period of iron 
fortification, and anemia rates in the same population decreased from 19% to 10% over 
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the same time period (Layrisse, et al. 1996).  The evidence presented indicates that after a 
dramatic reduction in 1994, the prevalence of anemia returned to the 1992 level, probably 
due to deterioration of quality food consumption, and dengue epidemic.  Whether the 
effect of is due to changing the iron fortification mandate from ferrous fumarate alone to 
ferrous fumarate and elemental iron (60:40 w/w for delivered iron) combination is 
difficult to determine.  Maize flour consumption decreased during this time period, with 
an increase of wheat flour consumption.  Regardless, iron fortification was shown to 
stabilize iron stores in the population. 
The Venezuelan study demonstrates that a small increase in total dietary iron can 
have a significant effect on reducing iron deficiency rates in that population.  The 
effectiveness of increasing dietary iron in deficient populations was further examined in a 
separate study, which showed that iron absorption from a labeled, ferric trisglycinate, 
fortified maize porridge was greater in iron deficient subjects than in iron replete subjects 
(Bovell-Benjamin, et al. 2000).  The efficiency of absorption increases with decreased 
iron status, which may have effects on apparent absorption rates of iron fortificants.  
Most of the studies described in Table 2.1 were conducted on healthy, iron replete 
subjects, which may indicate lower iron absorption rates.  Studies conducted on anemic 
rats are not reliable predictors of human iron absorption, because of phytase activity in 
the gastrointestinal track and lack of ascorbic acid requirement (Lopez, et al. 1998).   
 
Elemental Iron  
Elemental iron is the most common iron fortification form.  There have been no 
published human efficacy studies using elemental iron in maize foods.  Elemental iron, 
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while having a low bioavailability, has had high level of use in the United States, Latin 
America, and Western Europe in cereal products.  Bioavailability assays using reduced 
iron are inherently difficult to conduct because of difficulties in producing radiolabeled or 
stable isotopes of reduced iron forms that resemble commercial form sufficiently enough 
for meaningful comparisons.  Reduced iron is desirable from a food processing 
perspective as a fortificant because of its low reactivity and low cost; however reduced 
iron has very low bioavailability.  Reduced iron has been shown to have minimal 
negative organoleptic effects on fortified maize foods (Anderson, et al. 1976).  Recent 
research has indicated that there are significant differences in iron bioavailability from 
reduced iron powders based on surface area and particle size, where smaller, higher 
surface area particles have better bioavailability in rat hemoglobin repletion tests, and 
higher solubility at pH 1.0, and 1.7 (Swain, et al. 2003).  In studies summarized above 
(Walter, et al. 2004), the bioavailability of a laboratory produced, labeled, reduced iron 
isotope was assessed at 3.8% in tortillas fed to children.  Rats consuming fortified masa 
flour displayed no difference in iron utilization value from the unfortified masa flour 
(Hernández, et al. 2003).  Laboratory produced reduced iron powders are often not 
comparable to industrially processed reduced iron.  However, when considered in 
optimized iron fortification schemes, reduced iron may have benefits in certain settings 
and for certain food types.  More research on reduced iron must be conducted before 
recommendations for its use can be elaborated (Turner, 2002).   
 
EDTA  
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 Sodium Iron EDTA is currently the recommended form of fortification for maize 
foods.  Sodium Iron EDTA, or ferric EDTA as a fortificant has been shown to have high 
bioavailability.  Ferric EDTA has high solubility, and can overcome phytate inhibition 
(Mendoza, et al. 2001).  Several studies have indicated that ferric EDTA has higher 
bioavailability than other iron forms, and addition of sodium EDTA may influence the 
bioavailability of soluble iron forms.  When ferric EDTA was fortified into a maize 
porridge it displayed 10.5% bioavailability as compared to 4.7% from ferrous sulphate 
(Layrisse, et al. 2000a).  Addition of sodium EDTA to nixtamalized maize tortillas 
fortified with ferrous fumarate in a 2:1 molar ratio increased fumarate bioavailability 
significantly (Walter, et al. 2003), however this improvement was not shown when 
sodium EDTA was added to tortillas fortified with reduced iron (Walter, et al. 2004).  
Overall, iron EDTA fortification is highly beneficial, however is currently limited 
because of the high cost as compared to other iron fortificants (Table 2.4). 
 
Organic acids and iron fortification 
Use of organic acids to enhance iron bioavailability has been suggested as another 
strategy to enhance bioavailability (Teucher et al, 2004).  Limited studies have evaluated 
this idea in maize.  Co-fortification of ascorbate in particular with iron has been 
considered as a method of enhancing iron bioavailability because of the enhancing effect 
of ascorbate.  Wheat bread supplemented with phytate rich maize bran showed increased 
iron absorption when an ascorbate solution was applied to the bread post-baking before 
consumption (Siegenberg, et al. 1991).  Ascorbic acid fortification was shown to enhance 
intrinsic iron absorption in a maize tortilla meal from 1.2% to 3.4%; however, dietary 
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inclusion of ascorbate-rich foods resulted in more pronounced increase in iron absorption 
than that observed with the ascorbate fortification (Hallberg and Rossander, 1984).  The 
functional and organoleptic properties of maize food products fortified with iron and 
ascorbate have not been discussed, however in wheat flour foods, high levels of ascorbate 
have distinctive effects on dough rheology and product quality.  Additionally, ascorbate 
is not heat stable; therefore fortification of foods prior to cooking may not provide 
significant increases in iron absorption.  Social marketing and promotion of consumption 
of ascorbate rich foods may play a more vital role in influencing iron absorption rates 
than ascorbate co-fortification however, this too is being debated (Cook and Reddy, 
2001).  Other organic acids and their effects on iron bioavailability have not been 
evaluated. 
 
Fermentation  
Fermentation has been suggested as a means to enhance iron bioavailability 
through its potential role in reducing phytate from exogenous phytase in the fermentative 
organisms.  As a point of interest, traditional home fermented maize beer produced in 
iron containers has very high iron bioavailability.  The iron absorption from maize beer is 
high enough to put regular maize beer consumers at risk of iron overload.  And 
conversely, beers fermented in non-iron containers have much lower iron content than 
those fermented in iron containers (Derman, et al. 1980).  No studies have been 
conducted to identify if lactic acid bacteria fermented porridges have higher iron content 
and iron bioavailability when fermented in iron containers.  The beer study did indicate 
that maize solids content decreased iron bioavailability, despite increased iron content, 
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suggesting a fiber or protein based interaction with iron.  There is a lack of information 
on the iron bioavailability of traditional lactic acid fortified maize foods consumed in 
Latin America and Sub Saharan Africa, nor is there information on the efficacy of 
fortification in these same foods.  One study identified that maize-soy tempe flour (70:30 
w/w), which was fermented with Rhizopus oryzae, increased its iron solubility from 
2.46% to 5.51% as evaluated by the dialysis method (Tchango Tchango, 1995).  One 
could postulate that fermentation, through acidification and action of bacterial phytases 
acts to improve bioavailability, however no research to elucidate the mechanisms has 
been published.  These hypotheses regarding maize processing and fermentation have led 
to the research conducted in this dissertation in part 4. 
 
Phytate and Fiber in Bioavailability Reduction 
Fiber from maize is known to be high in phytate, which is a potent bioavailability 
inhibitor due to its tendency to chelate divalent metals, including calcium, iron and zinc.  
Phytate content is related to total fiber, in that maize fiber (pericarp and germ) has higher 
concentrations of phytate than endosperm.  Industrial processing, which is optimized to 
minimize dry matter losses, may increase phytate content by more efficiently milling 
maize bran for its inclusion in maize foods rather than remove it as a waste stream as in 
the traditional household methods.  Nixtamalization has been shown to marginally reduce 
phytate levels from 1113 mg/100 g to 727 mg/100 g after processing with 1.2% calcium 
carbonate (Urizar Hernández and Bressani, 1997).  These reductions in phytate are not 
sufficient to increase iron bioavailability, as reductions to levels less than 30 mg per 
entire meal are needed to see improvement in iron bioavailability (Hurrell, et al. 1992).  
 28
Industrially processed tortillas had significantly more phytate than home processed 
tortillas made from maize grown in the same region (Garzon, et al. 1984), likely due to 
increased net fiber content from inclusion of more pericarp in the final product.  No 
significant differences in phytate content, or iron absorption from maize porridge or 
pancake were found regardless of different industrial processing techniques, including 
extrusion, roller drying, amylase treatment, or home prepared commercial product 
(Hurrell, et al. 2002b).   
Most fiber in maize is insoluble (Nyman, et al, 1984)  Industrially processed 
tortillas were found to contain 6.60% neutral detergent fiber, 3.75% acid detergent fiber, 
and 2.89% hemicellulose (Reinhold and Garcia, 1979).  Diets with increasing amounts of 
fiber from a maize and bean mixture displayed lower relative biological value of iron 
assessed in rats compared to ferrous sulphate control (Garcia-Lopez and Wyatt, 1982), 
however this data may not directly correlate to humans as rats can metabolize phytate.  
The role of phytase, either through introduction of a commercial enzyme, or 
through fermentation or germination has been explored in relation to iron and zinc 
bioavailability.  Dephytinized maize porridge produced using commercial enzyme had 
8.9% iron absorption versus 1.8% in its native phytate counterpart (Hurrell, et al. 2003).  
Home dephytinization has been developed for maize foods, either through addition of 
commercial phytase to a 1:4 w/w maize:water slurry, followed by settling and 
decantation of supernatant (Manary, et al. 2002); or by soaking pounded maize flour in 
water in a 1:4 w/w ratio, followed by settling and draining prior to utilization (Hotz et al. 
2001).  Home addition of phytase caused a phytate reduction of 93%, while soaking 
without added enzymes caused a reduction of 52%.  Fermentation of a 70:30 maize:soy 
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mixture by Rhizopus oryzae was found to decrease phytate content by 46% (Tchango 
Tchango, 1995).  Hydrolysis of phosphate groups from phytate to create a lower level of 
inositol phosphates is the goal, as they are less inhibiting to iron uptake (Sandberg, et al. 
1999), and zinc bioavailabilty. 
 
Recommendations for Iron Fortification of Maize 
Recommendations exist for the fortification of maize flour with iron.  Sodium 
Iron EDTA has been recommended as the ideal fortificant for nixtamalized maize flour at 
20 mg/kg, with the next preference being ferrous fumarate, at 40 mg/kg, followed by 
microencapsulated ferrous sulphate or ferrous fumarate (No authors, 2002).  Ferrous 
sulphate, followed by ferrous fumarate are the iron fortificants of choice for degermed, 
sifted or bolted maize products, with double quantity fine mesh (<45um) electrolytic iron 
and microencapsulated ferrous sulphate or ferrous fumarate as secondary choices (PAHO 
et al. 2002).  Development of low cost ferrous sulphate microencapsulation could change 
recommendations, as ferrous sulphate typically displays the best iron bioavailability, but 
without microencapsulation can cause negative changes in organoleptic quality.  Iron 
compounds should be added to the level up to which they do not change the organoleptic 
qualities of the food, usually between 20ppm and 40ppm (PAHO et al. 2002). The use of 
fine mesh electrolytic iron, despite having low bioavailability, has high stability and low 
cost, and may be more practical for some settings.   
 
Biofortification for improving crops 
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The concept of using agronomic approaches to enhancing the nutritional value of 
crops is both one rooted in history, and yet a very modern approach to affecting 
micronutrient nutrition.  Historically, crop breeding was conducted to enhance yield and 
general nutritional quality, along with agronomic and economic adaptability.  Modern 
biofortification is defined as “the development of micronutrient-dense staple crops using 
the best traditional breeding practices and modern biotechnology.” (Nestel et al, 2006) to 
target enhancement of specific nutritional attributes, in particular micronutrient content 
and bioavailability.  Since the advent of the first major biofortification efforts, with 
theoretical work beginning in the 1980’s with studies into enhancing amino acid quality 
in seeds by transforming tobacco to express a brazil nut protein (Altenbach et al, 1988) 
through the widely publicized golden rice enhanced with b-carotene through expression 
of phytoene synthase from daffodils in the rice endosperm (Burkhardt et al, 1997),  many 
crops have been enhanced with various traits to enhance nutritional quality by 
biotechnology. 
Because of the nature of biofortification, which is the development of a self 
perpetuating means to provide a more nutrient rich diet, in theory, seed could be 
distributed with the intention of self perpetuation regrowing the seed each year.  This 
would eliminate the bulk of recurrent costs seen in fortification and supplementation 
initiatives and reduce the need for recurring intervention by governments or international 
development agencies (Bouis, 2003).   
There is some controversy, however, regarding the utilization of biofortified 
crops.  While biofortification has been developed using either traditional crop breeding 
techniques, it has also incorporated modern genetic engineering.  The acceptability of 
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genetically modified crops is still highly variable, because of various fears about genetic 
transfer, environmental impact, and changes in seed distribution modes affecting 
economic systems.  Proponents of genetic modification technology however suggest that 
consumers and legislative groups will be more willing to adopt genetically modified 
crops when a clear and well documented benefit to the consumers and producers can be 
seen (King, 2002).   
From a technical standpoint, biofortified crops have been suggested to be 
infinitely self perpetuating.  Genetically modified traits may not be readily passed on 
from generation to generation without significant monitoring programs, as some traits are 
not physiologically advantageous to the crops.  For example, phytate reduction for 
enhancing iron and other trace minerals bioavailability has been suggested as a means to 
improve bioavailability in maize (Mendoza et al, 1998), however phytate reduction has 
been shown to have a significant impact on yield, and germination quality (Pilu et al, 
2005).  Suggestions that biofortified crops will be self perpetuating without continuous 
evaluation and monitoring have been made (Graham and Welch, 1996; Graham et al, 
2001), however genetic traits bred in low resource areas could and should be suspect for 
genetic drift.   
 
Proof of concept studies 
Several crops have been evaluated for their potential modification to enhance iron 
content and bioavailability.  Germplasm of several staple crops has been evaluated for 
potential to breed for higher iron content without targeting specific genes.  This includes 
beans (Welch et al, 2000),  and maize (Oikeh, et al, 2003) where the beans showed 
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fractional absorption of 53 to 76% of total iron when assayed in an extrinsically labeled 
rat-based uptake assay, and the maize showed variation between 4% lower to 49% higher 
than the reference control as evaluated using the Caco-2 assay.  Non-specific increases in 
iron content do not evaluate the speciation of the iron within the seed, and as such may be 
increasing unavailable iron.  While the studies listed evaluated cofactors influencing iron 
bioavailability, including phytate and polyphenols, there is no consideration regarding 
environmental variability, and genetic segregation in the varieties suggested. 
One controversial study evaluated iron enhanced rice (IR68144–2B-2–2-3) 
(Gregorio et al, 2000) for its ability to improve iron status in Filipino women.  Enhanced 
rice (3.21 mg/kg Fe) was compared to typical rice (0.57 mg/kg Fe) over 9 months 
feeding.  In anemic women, no significant changes in iron status (hemoglobin, serum 
ferritin or total body iron) were seen, while in non-anemic women serum ferritin and total 
body iron increased.  As rice made up ~50% of the women’s’ caloric intake, it was 
anticipated that greater increases in iron status would have been seen, in particular with 
anemic women whose iron uptake should be upregulated.  It however has been postulated 
that the anemic women may have had multiple nutrient deficiencies or other health issues 
counteracting any benefit from the rice (Haas et al, 2005).   
Transgenic methods for enhancing iron content and bioavailability have also been 
developed for various crops.  Soybean ferritin has been overexpressed in rice, which 
when evaluated in a rat hemoglobin repletion model had bioavailability similar to rice 
fortified with ferrous sulphate (Murray-Kolb et al, 2002).  Human lactoferrin has also 
been expressed in rice, also showing similar bioavailability to ferrous sulphate fortified 
rice (Lonnerdal and Bryant, 2006).  Maize has specifically been modified to enhance iron 
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bioavailability by reducing phytate content.  Mutants of phytate have been evaluated, and 
shown to have 49% higher iron bioavailability as tortillas, and 50% as porridge, however 
differences between the normal and low phytate lines were significant when products 
were fortified (Mendoza et al, 2001, Mendoza et al, 1998).  One last strategy was to 
express transgenic soybean ferritin and Aspergillus niger phytase which showed 
approximately 3 fold higher bioavailability as assessed using the Caco-2 assay as 
compared to the wild type maize (Drakakaki et al, 2005).   
The idea of conducting genetic modification of plants using only coding sequence 
from the plant to be modified itself is gaining a good deal of interest, as it could 
potentially circumvent much of the negative impressions about transgenic modification.  
As discussed earlier, heme iron is a highly bioavailable source of iron (Proulx and Reddy, 
2006), and most plants have genes coding for hemoglobin proteins (Kundu et al, 2003).  
The overexpression of maize hemoglobin in maize is a proposed means to biofortify 
maize with highly bioavailable iron which will be discussed in this dissertation in part 5.   
 
Plant Hemoglobins 
The discovery that plants produce hemoglobin is not new, rather it was more than 
60 years ago that the first research into soy leghemoglobin was done (Kubo, 1939).  
Legumes have been shown to produce hemoglobin in response to infection with 
Rhizobium spp. as part of the nitrogen fixation process.  This is termed symbiotic 
hemoglobin.  The bacteria, which are facultative aerobes require oxygen transfer through 
the root tissues, while the nitrogenase enzyme responsible for conversion of atmospheric 
N2 to nitrate functions better in a low oxygen environment (Wittenberg et al, 1974).  The 
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presence of a hemoglobin acts as an oxygen diffusion and scavenging mechanism 
combined, based on the reversible oxygen binding of the hemoglobin.  More recent work 
has shown that many, and perhaps almost all plants have genetic coding for other 
hemoglobins not associated with nitrogen fixation.  The purpose of these non-symbiotic 
hemoglobins is not certain, however it is suggested that they may play a part in tissue 
differentiation in the xylem (Ross et al, 2001), anoxia (Taylor et al, 1994), flood tolerance 
(Taylor et al, 1994), light deprivation (Lira-Ruan et al, 2001) or nitric oxide metabolic 
pathways (Dordas et al, 2003).  The genetics and physiological significance of plant 
hemoglobins is reviewed in several articles (Garrocho-Villegas et al, 2007; Hebelstrup et 
al, 2007). 
As heme proteins, plant hemoglobins have been postulated to have similar 
bioavailability characteristics as their animal sourced proteins, making them a potential 
source of highly available iron.  This research is part of the first research project in this 
dissertation (part 3), showing how hemoglobin from soy root nodules compares in 
bioavailability to animal sourced hemoglobin.  Secondly, as most plants have genetic 
code for hemoglobin, the hemoglobin gene could be used for intragenic transformation of 
plants, in particular maize which has many nutritional factors inhibiting iron 
bioavailability.  This strategy is used for the research project in part 5 of this dissertation. 
 
Conclusion 
Iron deficiency is an enormous nutritional concern globally, and the development 
of new strategies for its alleviation is vital.  Food based strategies, in particular 
fortification, process modification, and biofortification have been shown to have strong 
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potential to be sustainable and cost effective means to alleviate iron deficiency.  Maize, 
and its food products are particularly problematic for fortification, as there is a lack of 
consensus for best fortification practices because of the diversity of maize processing 
technologies.  Novel strategies to improve iron bioavailability in maize foods should be 
developed, and this dissertation aims to describe three novel approaches to improving 
iron bioavailability in maize products.  This includes fortification of maize tortillas with 
plant hemoglobins, processing maize in ways to better enhance bioavailability of intrinsic 
or fortification iron, and lastly biofortification using intragenic overexpression of maize 
hemoglobin genes to increase the amount of bioavailable iron in maize.  With the advent 
of a variety of new technologies, hopefully iron deficiency can be alleviated in 
populations around the world. 
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Figures 
 
 
 
 
Figure 2.1. Body stores of Iron
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Figure 2.2. A schematic diagram of iron uptake in intestinal epithelial cells.  From Dunn 
et al. (2006). 
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Figure 2.3 Interplay of Key Proteins in Iron Homeostasis, From Fleming et al (2005). 
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Abstract 
Heme iron has been identified in many plant sources - most commonly in the root 
nodules of leguminous plants, such as soy. Our objective was to test the effectiveness of 
soy root nodule (SRN) and purified soy hemoglobin (LHb) in improving iron 
bioavailability using an in vitro Caco-2 cell model, with ferritin response as the 
bioavailability index. We assessed bioavailability of iron from LHb (either partially 
purified (LHbA) or purified (LHbD)) with and without food matrix and compared it with 
that from bovine hemoglobin (BHb), ferrous sulfate (FeSO4), or SRN. Bioavailability of 
each treatment was normalized to 100% of the FeSO4 treatment. When iron sources were 
tested alone (100 ug iron/mL), ferritin synthesis by LHbD and BHb were 19% (p > 0.05) 
and 113% (p < 0.001) higher than FeSO4, respectively. However, when iron sources were 
used for fortification of maize tortillas (50 ppm), LHbA and BHb showed similar 
bioavailability, being 27% (P < 0.05) and 33% (P < 0.05) higher than FeSO4. Heat 
treatment had no effect on heme iron but had a significant reduction on FeSO4 
bioavailability. Adding heme (LHbA) iron with nonheme (FeSO4) had no enhancement 
on nonheme iron absorption. Our data suggest that heme iron from plant sources may be 
a novel value added product that can provide highly bioavailable iron as a food 
fortificant. 
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Keywords: Iron bioavailability; heme iron; soy root nodules; leghemoglobin 
 
Introduction 
Iron deficiency is a major nutritional problem, affecting over 2 billion people (1). 
Fortification of foods with iron has been a successful strategy for improving iron content 
of foods; however, the bioavailability of iron fortificants is often decreased due to the 
presence of inhibitors within the food matrix. Iron bioavailability is higher from heme 
iron sources because of lack of inhibition from chelating compounds including 
polyphenols and phytate and because of its intact absorption by pathways different than 
those of nonheme iron (2). Heme iron in the human diet is generally present in animal 
sources as a part of hemoglobin and myoglobin but is also found in many invertebrates, 
bacteria, fungi, and widely distributed in the plant kingdom (3). However, these heme 
proteins currently do not provide a significant amount of iron in human diets. Plant 
hemoglobins are most commonly found in nodulating legumes as part of the symbiotic 
nitrogen fixation pathway; however, nonsymbiotic hemoglobins also exist in many plants 
with diverse and yet undescribed roles in plant physiology (4). 
Leghemoglobin (LHb), a symbiotic hemoglobin, is a monomeric heme protein 
originally identified in soybean root nodules and has been studied extensively (5, 6). 
Because of its high affinity for oxygen, LHb makes less oxygen available, enhancing the 
nitrogen fixation process. The nitrogenase enzyme produced by symbiotic bacteria within 
legume roots requires an anaerobic environment, and therefore, the plant produces heme 
protein that is capable of scavenging oxygen within the cytosol of the root, resulting in a 
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low-oxygen environment ideal for nitrogen fixation (7). Leghemoglobin accumulates iron 
in roots creating a large iron store. Iron levels of up to 2.5 mg total iron/g dry weight 
basis have been measured in soy nodules, with up to 26% of the total iron in heme form 
in the unpurified root (8). Most researchers are interested in the physiological role and 
structure of hemoglobin in the plant, but to our knowledge no studies have been reported 
on the use of plant hemoglobins for improving iron bioavailability of human diet. 
Caco-2 cells are human intestinal adenocarcinoma cells exhibititing enterocyte-
like biochemical and morphological characteristics and have been used widely for 
nonheme iron bioavailability studies (9, 10). Heme bioavailability in Caco-2 cells is not 
well studied, but recent work has shown that these cells synthesize enzymes involved in 
heme uptake and metabolism, in particular hemeoxygenase (11), and that the mechanisms 
of heme transport are similar between humans and Caco-2 cell models (12). This 
evidence makes the Caco-2 cell model appealing for its potential in evaluating heme iron 
bioavailability. 
The objective of this study was to determine the iron bioavailability of crude soy 
root nodule extract (SRN) and two purified soy leghemoglobins and to compare their 
bioavailability with that of bovine hemoglobin (BHb) using the Caco-2 model. The 
underlying objective of this study is to introduce the concept of using plant hemoglobin 
as a heme iron source in diets that are consumed by humans and to promote further 
research into this area. 
 
Materials and Methods 
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LHb Preparation. Soybean plants (cultivar - OAC Bayfield) were field raised in 
sandy loam soil at Cambridge Research Station, University of Guelph, during the 2002 
growing season on cropland used for potatoes in the prior two growing seasons. Seed was  
inoculated with Hi Stick Prep Rhizobium japonicum (Becker Underwood Canada, 
Saskatoon, Saskatchewan) at 1.8 g inoculant per 1 kg seed application rate. Fields were 
irrigated as needed. The root nodules were mechanically harvested at R7 maturity, 
removed from root structures, and lyophilized. Dried nodules were ground to pass a 30 
mesh screen. Crude SRN fraction was prepared by reconstitution of dried nodule powder 
with water 1:5 w/w, followed by centrifugation (5000g for 30 min). Supernatant was 
collected, lyophilized, and stored at -20 °C until use. The aqueous extract was also used 
to prepare partially purified LHb (referred to as LHbA) by using 50-80% ammonium 
sulfate ((NH4)2SO4) precipitation, followed by desalting by dialysis with water. The 
desalted protein extract was lyophilized and stored at -20 °C for further use. Ion exchange 
chromatography with DEAE Sepharose (GE Healthcare, Piscataway, NJ) was used to 
further purify the LHb obtained from (NH4)2SO4 precipitation. The column was 
equilibrated to pH 7.0 and ran with a linear gradient elution starting with deionized (DI) 
water and ending with 1 mol/L NaCl at pH 7.0. Eluants that were in the 405 nm 
absorbance peak were pooled, desalted by dialysis, and lyophilized (referred to as 
LHbD). LHbD was used in the initial studies without food matrix, and LHbA was used in 
all tortilla fortification studies. Total iron was determined in samples by nitric acid 
digestion, and nonheme iron was determined by trichloroacetic acid protein precipitation 
method with a modification using ferrozine as a chromogen (13, 14). Purity of protein in 
extracts and degradation of globin during in vitro digestion were assessed by SDS-PAGE 
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using 10-20% polyacrylamide Tris-Tricine precast gels (Biorad, Hercules, CA) in a 
Ready Gel Cell (Biorad), and molecular weight was estimated by comparison with 
standards (Biorad). Gels were fixed using 5% glutaraldehyde (Electron Microscopy 
Sciences, Ft. Washington, PA), followed by staining in 10% (v/v) aqueous acetic acid 
with 0.025% Coomassie Brilliant Blue G250 (Biorad) and destaining with 10% (v/v) 
aqueous acetic acid. Protein purity was estimated by gel optical density using QuantOne 
software (BioRad). 
Tortilla Preparation. Unfortified masa harina (Ultrawhite #1 tortilla flour, 
Cargill Foods, Paris, IL) was fortified with 50 ppm iron with one of the following: SRN, 
LHbA, BHb (98% pure, Sigma Aldrich, St. Louis, MO) or ferrous sulfate (FeSO4) 
(Sigma Aldrich). Masa harina (200 g) was mixed with fortificant, sealed in a plastic 
container, and thoroughly mixed by shaking 2 min. Masa harina was reconstituted with 
DI water (1:2 w/w), weighed to 25 g portions, flattened by tortilla press, and fried at 
200°C on a Teflon pan, 2 min on each side. Tortillas were lyophilized and ground to pass 
a 30 mesh screen, sealed, and stored in the dark at room temperature. Iron content of 
lyophilized tortilla was verified using the method described above for total iron, and the 
biovailability was assessed using Caco-2 cells.  
In Vitro Digestion. For experiments conducted without food matrix, SRN, 
LHbD, BHb, and FeSO4 were weighed to provide 1 mg iron in 10 mL final volume (100 
ug/mL). Initially the iron sources were dissolved in 1 mL of a 140 mmol/L NaCl, 5 
mmol/L KCl solution prior to digestion. Fortified tortilla samples were weighed to 
provide 200 g total iron (~3.5 g to represent 50 ppm iron) and suspended in 5 mL of DI 
water. Pepsin was prepared by solubilizing 0.2 g of porcine pepsin A (1:60000) in 5 mL 
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of 0.1 mol/L HCl. Pancreatin and bile solution were prepared by dissolving 0.05 g of 
porcine pancreatin (4 x USP) and 0.3 g of bile extract in 25 mL of 0.1 mol/L sodium 
bicarbonate (NaHCO3). Trace minerals were removed from pepsin and pancreatin 
mixtures by treatment with Chelex-100 (BioRad) for 30 min, filtered through a separation 
column, and re-eluted with 5 mL of 0.1 mol/L HCl or 10 mL of 0.1 mol/L NaHCO3, 
respectively (15). The pH of all samples, either with or without food matrix, was adjusted 
to pH 2.0 with 0.5 mol/L HCl, pepsin was added (0.5 mL), and the digest was incubated 
at 37 °C for 1 h on an orbital shaker at 200 rpm. The pH was then adjusted to 6.5 with 1.0 
mol/L NaHCO3 solution, and 2.5 mL of pancreatin solution was added. The samples were 
again incubated with shaking at 37 °C for 15 min and centrifuged, and the supernatant 
was then heat treated for 4 min at 100 °C in a boiling water bath to inactivate proteolytic 
activity as described by other researchers (16). Samples in aqueous matrix were adjusted 
to a final 10 mL volume with 140 mmol/L NaCl and 5 mmol/L KCl to provide a final 
concentration of 100 ug/mL. Samples with tortilla matrix were adjusted to final volume 
of 20 mL using DI H2O to provide a 10 g/mL iron. All digests were centrifuged at 5000g 
for 5 min, and supernatants were used for cell bioavailability experiments. 
Cell Culture. All reagents for cell culture work were from Sigma Aldrich or 
Gibco BRL (Grand Island, NY) unless otherwise mentioned. Caco-2 cells were 
purchased at passage 17 from American Type Culture Collection (Rockville, MD). The 
following experiments were conducted during passages 20-26. Cells were grown in a 
culture flask with Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% fetal bovine 
serum (FBS), 1% v/v nonessential amino acids, and 1% v/v antibiotic-antimycotic 
solution. Cells were maintained at 37 °C in an incubator with 5% CO2. Media was 
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changed 3 times weekly. At 7 d, the cells were rinsed with Earle’s Balanced Salt Solution 
(EBSS), trypsinised to dissociate the cells, centrifuged at 22.6 g for 5 min. The cells were 
seeded at a density of 5.6 x 103 cells/cm2 in a 75 cm2 culture flask for continued growth, 
or seeded on collagenized (Type 1 Rat tail collagen) 12-well cell culture plates (Corning 
Costar) at a density of 5 x 104 cells/cm2 for iron bioavailability experiments. The cell 
culture plates were maintained under incubator conditions similar to those of the cell 
culture flask. Iron bioavailability experiments were conducted 15 d post seeding after 
rinsing with EBSS. 
Iron Bioavailability by Caco-2 Cells. Bioavailability of heme sources was 
determined using ferritin concentration as an index of bioavailable iron in response to 
iron uptake (15). Serum free media modified from a published study (14) [DMEM with 
1% v/v nonessential amino acids, 1% v/v antibiotic-antimycotic solution, 10 mmol/L 
PIPES (piperazine-N,N-bis-(2-ethanesulfonic acid), hydrocortisone (4 mg/L), insulin (5 
mg/L), selenium (5 ug/L), triiodothyronine (34 ug/L), and epidermal growth factor (20 
ug/L)] was applied to the cell culture (0.5 mL) before adding an equal volume (0.5 mL) 
of sample supernatants and was incubated for 2 h. An additional 0.5 mL of serum-free 
media was added to the initial 1 mL, followed by a further incubation for 22 h. After 24 h 
total incubation, the samples were removed by aspiration from the cell culture wells, and 
cells were rinsed with 1 mL of EBSS. The cells were then lysed by addition of 0.5 mL of 
deionized water to each well and sonicated with a probe-type sonic dismembrator at 
lowest setting (<1 W output) for 15 s. Total cellular protein was determined in the lysates 
by the Bradford Coomassie Assay, (Pierce Laboratories, Rockford, IL). Ferritin in the 
lysates was determined by radioimmunoassay (Fer-Iron II, Ramco Laboratories, Stafford, 
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TX) and measured using Cobra-II Gamma Counter with SpectraWorks software (Packard 
BioSciences, Meriden, CT). After normalizing ferritin concentration to cell protein 
concentration, the values were normalized, defined as percentages compared to FeSO4, 
and expressed as relative biological values (RBV). 
Effect of Heat on Fortificant Bioavailability. By adding the iron fortificant to 
the masa harina (subjected to heating) or to freeze-dried unfortified tortilla powder 
(subjected to no heating), the effect of heat treatment on iron bioavailability was assessed 
by using Caco-2 cells as described above. 
Effect of Heme on Nonheme Iron Bioavailability. Tortillas were made by 
fortifying masa harina to a total of 50 ppm iron using blends comprised of 0, 25, 50, 75, 
or 100% iron from LHb, with the remaining iron from FeSO4. Each fortification blend 
was then evaluated for iron bioavailability using the Caco-2 cells. 
Statistical Analysis. Differences in RBV among treatments was determined using 
ANOVA with Tukey’s multiple comparison test. For assessing the effect of heat 
treatment on bioavailability, Student’s t test was used to compare the bioavailability of 
fortification before and after heat treatment. All mean differences were deemed 
significant at p < 0.05. Analyses were performed using GraphPad software (Graph-Pad 
Prism version 4.02 for Windows, San Diego, CA). 
 
Results and Discussion 
As per the SDS-PAGE gel (Figure 3.1), the LHb extract had the largest band at 
14 kDa, which is the reported molecular weight of LHb (6). LHb purity increased from 
21% in the SRN extract to 54% in the LHbA and to 73% in the LHbD extracts, 
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respectively, as determined by optical densitometry comparing the density of the 14 kDa 
bands to the total lane density. No 14 kDa band was found after the pepsin digestion by 
SDS-PAGE for either LHbA or BHb, suggesting globin from these proteins is completely 
degraded (data not shown).  
The results of the iron bioavailability study using aqueous solutions of SRN, 
LHbD, and BHb are shown in Figure 3.2. The relative biological values (RBV, 
compared to 100% with FeSO4) were 28 ± 10%, 19 ± 17%, and 113 ± 13% higher than 
FeSO4, respectively, (mean ± SEM) for SRN, LHbD, and BHb. The iron bioavailability 
of BHb was 2-fold higher than all other samples (p < 0.001), but the iron bioavailability 
of SRN and LHbD was similar compared to that of FeSO4. Since the bioavailability of 
SRN and LHbD was similar, LHbA, we found no advantage using the pure fraction. 
Hence, the partially purified LHbA fraction was used for tortilla fortification studies. 
Unlike the previous results without food matrix, the RBV for 50 ppm fortified 
tortillas with SRN was 19% lower than that of FeSO4 , but was not significantly different 
(Figure 3.3).  The LHbA and BHb tortillas exhibited 27 ± 6% and 33 ± 10% higher 
bioavailability than FeSO4 (P < 0.05) and with no difference between them. Although 
based on dry weight, total iron content varied for SRN, LHbA, and BHb (1.42, 1.7, and 
2.9 mg/g, respectively), and weight adjustment provided equal amounts of total iron in all 
the treatments prior to in vitro digestion. The heme iron content also varied based on dry 
weight basis, 1.0, 1.4, and 2.3 mg/g for SRN, LHbA, and BHb, respectively, but the 74-
83% of added iron was in heme form in all the treatments.  
Heat displayed no significant impact on bioavailability other than on FeSO4 
bioavailability (Figure 3.4). The bioavailability of FeSO4 was 36 ± 6% lower in samples 
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fortified before cooking (p < 0.001), indicating that iron bioavailability was decreased by 
heating the fortificant during cooking. Although not significant, SRN, LHb, and BHb 
showed increases in bioavailability with heating. Nonheme iron bioavailability was not 
affected by adding heme iron from the LHbA at any concentration raging from 25 to 75% 
(data not shown). 
Heme iron bioavailability has long been known to have higher bioavailability (18-
29%) than nonheme iron (<10%) (17), because heme iron has a different uptake pathway 
than nonheme iron. Heme is released from the globin protein and iron is absorbed intact 
with porphyrin into the mucosal cells (18). High bioavailability of heme can be partly 
attributed to this different pathway and partly to the lack of inhibition from dietary factors 
such as phytate and polyphenols which strongly inhibit nonheme iron absorption (2, 17). 
Currently heme iron in the human diet is almost exclusively from animal sources, 
and its intake has been shown to have a positive correlation with iron status (19, 20). 
Indeed, one major recommendation for improving iron status in populations is to 
incorporate sources of heme iron in the diet because of its high iron bioavailability (21). 
However, the  incorporation of animal-sourced heme iron is often unfeasible because of 
economic costs or because cultural and religious barriers forbid the consumption of meat 
in populations where iron deficiency is prevalent.  
While it has long been known that plants produce heme proteins, they have not 
been extensively studied in human iron nutrition. A recent rat hemoglobin repletion study 
by one of the authors showed a bioavailability of 59% with SRN compared to FeSO4 
which was similar to a 60% bioavailability with BHb (8). Unlike human studies, the 
lower bioavailability of BHb compared to FeSO4 raises some concern of this model for 
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measuring heme iron absorption; however, the similarity in bioavailability between LHb 
and BHb promoted this current study. Since the rat is not shown to be the most reliable 
model to assess human bioavailability (22), we have used a cell culture model to further 
evaluate LHb iron bioavailability studies. The Caco-2 cell model is appealing because of 
its low cost, reliability, and wide use for nonheme iron bioavailability (9, 10). Interest in 
the use of this model for studying heme bioavailability and metabolism has been limited, 
but is increasing, as is described in recent studies (11, 12). Heme iron absorption in Caco-
2 cells was shown to be affected by hemeoxygenase induction, more importantly by iron 
status similar to humans (12). Our results showing higher bioavailability of BHb 
compared to FeSO4 alone or with food further promote that the Caco-2 cell model may 
indeed be useful for evaluating heme iron bioavailability. Since iron within the epithelial 
cells has a similar metabolic fate regardless of its source, either heme or nonheme, ferritin 
may be a useful index of bioavailability, regardless of the source of the iron (15).  
There are a number of reasons why a discrepancy exists in the bioavailability 
results in Figures 3.2 and 3.3. The first possible explanation is the difference in the iron 
concentrations in the uptake solutions, which was 10-fold higher in aqueous solution 
experiments (Figure 3.2), and the presence of solid milieu of food affecting uptake. Since 
we reported the values relative to FeSO4, it is also important to consider how FeSO4 
bioavailability is affected by the food matrix when comparing the results from different 
experiments. Differences in FeSO4 bioavailability greatly influence the RBV of the 
treatments. Hence, the low RBV of BHb in Figure 3.3 should not be viewed as a 
reduction of bioavailability in the presence of food. Iron chemistry and solubility is 
highly dependent on the digestive milieu. Lower LHbD bioavailability compared to that 
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of BHb in aqueous solution (Figure 3.2) might also be attributed to the differences in 
globin fractions of those two proteins. Although structural homology between these two 
proteins is high (5), the amino acid sequence of bovine α or β globin compared to soy 
globin shows low sequence homology when compared with BLOSUM-62 (NCBI 
Protein-Protein BLAST). Globin protein has been shown to increase the bioavailability of 
heme iron (12), and the presence of hydrophobic peptides hydrolyzed from the globin 
protein during digestion is known to affect the absorption of heme iron (23). It is possible 
that globin degradation may be different between LHb and BHb and the solubility of iron 
may be better maintained in BHb with its globin degradation products. It is also possible 
that there may be a lipid enhancing effect in the BHb which is not present in the LHb. 
Since the BHb was derived from bovine reticulocytes, it may have trace amounts of lipids 
which in the aqueous environment may influence iron bioavailability (24). Our results 
suggest that LHb may not be anymore beneficial than FeSO4 if it is used as a supplement. 
However, our goal was to assess bioavailability with food, which is more applicable for 
determining the use of LHb for food fortification. 
The low bioavailability of SRN with tortilla may be due to the presence of 
nonhemoglobin fractions in the extract compared to LHbA or BHb. Since we have to use 
a 30% higher amount of this fraction to get equal amounts of heme iron compared with 
LHbA, its use in food fortification may be limited due to organoleptic probelms. Because 
of high purity, we can use a lesser amount of LHbD to avoid acceptability problems, but 
it adds higher cost for preparation. However, LHbA obtained from (NH4)2SO4 
fractionation had a reasonable level of purity as well as a bioavailability with tortillas 
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similar to that of BHb (Figure 3.3), suggesting the usefulness of this fraction in food 
fortification. 
The RBV of BHb decreased, from 113% to 27% of FeSO4, when heme iron was 
fortified into tortillas compared to without food matrix. Besides the lower concentration 
of fortificant in this experiment, the lower bioavailability of BHb with the food matrix 
might be due to the influence of calcium in tortillas due to nixtamalization treatment with 
calcium hydroxide. Calcium has been shown to decrease the bioavailability of heme iron 
bioavailability as well as nonheme iron (25, 26). Another explanation might be that 
FeSO4 availability is low in aqueous solution due to its low solubility at neutral pH 
without any chelating agents. Since the results are expressed as RBV to FeSO4, the 
decrease in bioavailability of BHb should be viewed as higher bioavailability of FeSO4 in 
the presence of tortillas compared to without food matrix. Unlike the results in Figure 
3.2, BHb and LHb bioavailability is similar in Figure 3.3, suggesting that there might be 
differences in iron solubility or the effect of calcium. 
Ferrous sulfate is considered an ideal positive control for bioavailability 
assessment because of its high bioavailability in most food products. However it is not 
practical for maize foods fortification because of the adverse organoleptic effects caused 
by FeSO4 catalyzed lipid peroxidation and changes in color of the food itself (27). As 
such, FeSO4 is not currently recommended for maize foods fortification (28), but our 
results with LHbA showing bioavailability higher than FeSO4 with food offer a 
promising new alternative iron fortification scheme.  
The effect of heat on the bioavailability of heme iron sources is minimal, unlike 
FeSO4 which decreases in bioavailability during heating. Although not significant, the 
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heat treatment tends to improve the bioavailability of heme iron, which may be due to 
denaturation of the globin proteins and enhancement of hydrophilic interactions. 
However, the decrease in FeSO4 bioavailability during heating might be due to 
interaction of iron with maillard browning products (29) or from oxidation of ferrous iron 
to the less bioavailable ferric form (30). It appears that the heme pyrolle provides a 
protective effect against the heat effect. 
No beneficial effect of heme/nonheme iron combinations on bioavailability, 
compared to both irons alone at the same concentration, was shown in our study, 
suggesting that heme does not enhance the bioavailability of nonheme iron. Therefore, 
the positive effects of meat on nonheme iron absorption may be due to factors in meat 
other than the hemoglobin fraction. The enhancing effect of animal tissue on nonheme 
iron bioavailability was generally attributed to the “meat factors” rather than hemoglobin 
(31-32). 
Conclusion 
Our results showing the bioavailability of hemoglobin from soy root nodules 
similar to that of heme iron from animal sources when added with tortillas provide a 
unique alternative fortificant. However, no advantage of using LHb as a supplement was 
found because its bioavailability is similar to commonly used FeSO4. Because of the 
known minimal inhibition of heme iron, unlike nonheme iron, by dietary factors and 
because of the high heat stability of this iron form, plant hemoglobins may have great 
potential to be used as a fortificant for improving nutrition. Soy root nodules have no 
current use in agriculture production and as such may provide a novel value-added 
product for soy producers. Given optimal nodulation conditions, 2-3 plants would 
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provide sufficient LHb to meet 25% of the recommended daily requirement of iron, 
assuming 25% of heme iron absorption. The use of plant hemoglobins in iron nutrition 
warrants further study of sensory and safety issues related to fortification to make this a 
feasible reality. 
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Figure 3.1. SDS-PAGE purity analysis of LHb protein fractions (Each lane contained 
0.25 mg of protein.) Lane 1: standard 1 (14.4 - 97.4 kDa). Lane 2: soy root nodule (SRN) 
extract. Lane 3: 80% (NH4)2SO4 precipitated fraction of the SRN extract (LHbA). Lane 
4: DEAE purified fraction following (NH4)2SO4 precipitation (LHbD). Lane 5: standard 2 
(6.5 - 26.6 kDa). 
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Figure 3.2. Iron bioavailability of SRN (soy root nodule), LHbD (DEAE purified 
fraction of soy leghemoglobin), BHb (bovine hemoglobin), and FeSO4 in aqueous 
solutions. # Relative biological value (RBV) = ng ferritin/ µg cellular protein relative to 
the mean FeSO4 value. Bars (mean ± SE, n=5) with similar letters are not significantly 
different (p > 0.05) based on ANOVA with Tukey’s multiple comparison test. 
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Figure 3.3. Iron bioavailability of tortillas fortified with SRN (soy root nodule), LHbA 
((NH4)2SO4 purified soy leghemoglobin), BHb (bovine hemoglobin), and FeSO4 with 50 
ppm iron. #Relative biological value (RBV) = ng ferritin/µg cellular protein relative to 
the mean FeSO4 value. Bars (mean ± SE, n ) 9-10) with similar letters are not 
significantly different (p > 0.05) based on ANOVA with Tukey’s multiple comparison 
test. 
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Figure 3.4. Effect of heat treatment on iron bioavailability of fortified tortillas (heated 
minus not heated). Bioavailability was measured from iron sources added before (heated) 
and after making tortillas (not heated). #Relative biological value (RBV) =  ng ferritin / 
µg cellular protein relative to the respective FeSO4 value run simultaneously with each 
treatment. Student t test was used to compare heated and not heated treatments (mean ± 
SE, n = 9-10) for each iron source. *p < 0.05. SRN = soy root nodule extract, LHbA = 
(NH4)2SO4 purified soy leghemoglobin, BHb = bovine hemoglobin. 
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Abstract 
Maize is one of the most important cereal crops for human consumption, yet it is of 
concern due to its low iron bioavailability. The objective of this study was to determine 
the effects of processing on iron bioavailability in common maize products and elucidate 
better processing techniques for enhancing iron bioavailability. Maize products were 
processed to represent different processing techniques: heating (porridge), fermentation 
(ogi), nixtamalization (tortillas), and decortication (arepas). Iron and phytate contents 
were evaluated. Iron bioavailability was assessed using the Caco-2 cell model. Phytate 
content of maize products was significantly reduced by decortication (25.6%, p = 0.003) 
and nixtamalization (15%, p = 0.03), and iron content was reduced by decortication 
(29.1%, p = 0.002). The relative bioavailability (RBA, compared to 100% bioavailability 
of porridge with FeSO4) of ogi was significantly higher than that of other products when 
fortified with FeSO4 (p < 0.001) or reduced iron (p < 0.001). Addition of lactic acid (6 
mg/g of maize) significantly increased iron solubility and increased bioavailability by 
about 2-fold (p < 0.01), especially in tortillas. The consumer panel results showed that 
lactic acid addition does not significantly affect the organoleptic characteristics of 
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tortillas and arepas (p = 0.166 and 0.831, respectively). The results suggest that 
fermentation, or the addition of small amounts of lactic acid to unfermented maize 
products, may significantly improve iron bioavailability. Lactic acid addition may be 
more feasible than the addition of highly bioavailable but expensive fortificants. This 
approach may be a novel means to increase the iron bioavailability of maize products to 
reduce the incidence of iron deficiency anemia. 
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Introduction 
Iron deficiency is the most prevalent nutritional deficiency worldwide, affecting 
over 2 billion people (1). Maize ranks as the largest cereal crop produced globally, and 
the third most important grain for human consumption, with 116 million tons consumed 
as food in 2003 (2). Due to the low iron bioavailability of maize, research is mainly 
focused on fortification strategies appropriate to maize products (3). Little attention, 
however, has been paid to food matrix effects in maize, except for phytate content. 
Because of the complexity and variation in maize processing, we can expect changes in 
the food matrix other than changes in phytate that will affect iron bioavailability.  
Fortification is a common practice for increasing iron content of maize products. 
However, the highly bioavailable iron fortificant, ferrous sulfate (FeSO4), is highly 
unstable and induces oxidative rancidity; on the other hand, elemental iron is very stable 
but has low bioavailability. Sodium iron EDTA has been proposed as the most effective 
fortificant, but its use is minimal due to its high cost (4). The fortification of maize with 
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iron has been minimally successful at combating iron deficiency because of the high level 
of phytate in maize, which significantly inhibits absorption of both intrinsic and added 
iron (5).  
Traditional maize processing and its industrial adaptations are highly diverse and 
differentiated by cultural preferences. In general, traditional maize processing can be 
broadly categorized by four main processing techniques: heating, nixtamalization, 
decortication, and fermentation (6). Many of the contradictory results with maize iron 
fortification studies may be due to the use of products developed through different 
processing methods, thereby not accounting for strong food matrix effects. A great level 
of interest is being given to defining best practices for maize product fortification (4); 
however, only a few studies have focused on the specific effects of processing on iron 
content and solubility (7, 8), and none to our knowledge have taken a systematic 
approach comparing the different processes described above across the same starting 
material, especially including a bioavailability assessment. 
The hypothesis of this study is that different processing techniques will affect the 
iron bioavailability of maize products, and, in particular, fermentation or lactic acid 
addition may beneficially affect iron bioavailability. The objective of this study is to 
evaluate the effect of the primary traditional processing techniques for maize, heating, 
nixtamalization, fermentation, and decortication, on phytate and iron content, iron 
solubility, and iron bioavailability. It is anticipated that by understanding the effects of 
processing, appropriate techniques can be transferred from one traditional process to 
another to improve iron bioavailability. 
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Experimental Methods 
Maize (cv. Northrup King 60-B6, 2004 harvest) was obtained from the Iowa 
Grain Quality Laboratory and cleaned by manual sorting to remove extraneous material 
and broken seeds. All chemicals were obtained from Sigma Aldrich (St. Louis, MO) 
unless otherwise noted. Mass balance technique, conducted in duplicate, was used to 
determine iron and phytate losses. Deionized water was used throughout the study.  
Porridge Preparation (Heat). Maize (200 g) was ground in a coffee grinder to 
pass a 30-mesh screen (maize meal). The maize meal was mixed with 300 mL of H2O 
and heated in a glass pot with stirring until the maize became stiff (porridge).  
Arepa Preparation (Decortication). Maize (200 g) was tempered to raise the 
moisture content to 50%. Bran and germ were separated by using a blunt blade blender 
and mixed with water, and the floating fraction was collected (bran + germ). The 
endosperm fraction was run repeatedly through a KitchenAid grinder until smooth (arepa 
starch). Water was added to make the starch material malleable. Cakes of 50 g (1 cm 
thick) were formed and dry-fried in a Teflon-coated pan at 200 °C for 5 min per side 
(arepa). 
Tortilla Preparation (Nixtamalization). Calcium hydroxide (400 mL of a 1% 
solution) was mixed with 200 g of maize in a glass pot. The maize mixture was cooked at 
80 °C for 30 min and then left to steep at room temperature for 12 h. The steep liquid was 
drained, and the maize was rinsed three times with H2O. The steep and rinse waters were 
retained for analysis (nejayote). The maize was run through the KitchenAid grinder 
repeatedly until smooth (masa). Water was added to make the masa malleable. Balls (25 
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g) were formed, pressed flat in a tortilla press, and dry-fried in a Teflon-coated pan at 
200°C for 2 min per side (tortilla). 
Ogi Preparation (Fermentation). Maize (200 g) was steeped in 300 mL of H2O 
at 25 °C for 24 h. The maize and steep water were blended in a Waring blender until 
smooth and then fermented spontaneously over 24 h at 25 °C (ogi, uncooked). The 
fermented maize was then boiled in a glass pot until stiff (ogi, cooked). 
All maize samples were lyophilized, ground in a coffee grinder, passed through a 
30-mesh sieve, and stored frozen at -20 °C for further use. 
Iron Content. Total iron content in maize products and fractions was measured 
by a wet ashing method, followed by a colorimetric assay (9, 10). Briefly, 1 g of sample 
was wet-ashed with nitric acid in a microwave at 250 W until the resulting liquid was 
clear. The sample was diluted to 10 mL, and the iron concentration was measured 
colorimetrically using ferrozine [3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-4’,4”-
disulfonic acid sodium salt] as a chromogen in a microplate assay. 
Phytate Content. Phytate was measured using anion exchange chromatography 
(11). Samples (1 g) were subjected to extraction with 2.4% HCl, centrifugation, and 
filtration. Supernatant was mixed with 0.75 mol/L NaOH and a 0.1 mol/L Na2EDTA 
solution and run on an AG1-X4, 100-200 mesh, chloride form ion-exchange resin (Bio-
Rad, Hercules, CA) in a 1.5 x 30 cm column. Phytate was eluted with a 0.7 mol/L NaCl 
solution, heat digested with H2SO4 and HNO3, and then reconstituted with H2O. 
Phosphorus content was measured using ammonium molybdate and 4-amino-3-hydroxy-
1-naphthalenedisulfonic acid in 0.15 mol/L Na2SO3 and 0.92 mol/L NaHSO3, and inositol 
hexaphosphate equivalents were calculated to estimate phytate concentration. 
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In Vitro Digestion. After preparation of the products with maize, freeze-dried 
products were fortified with 50 ppm of iron by adding FeSO4 or reduced iron (RedFe, 
American Ingredients, Kansas City, MO) prior to digestion. Samples were prepared for 
bioavailability assessment as described earlier (12). Fortified samples were weighed to 
deliver 200 ug of total iron (~3.5 g), mixed with water, and adjusted to pH 2.0 using 5 M 
HCl. Pepsin solution [porcine pepsin A (1:60000) in 0.1 mol/L HCl] was added and 
incubated at 37 °C with shaking for 1 h. Following the pH adjustment to 6.0, pancreatin 
and bile solution were added [porcine pancreatin (4xUSP) and bile extract in sodium 
bicarbonate solution], and incubation was continued for 15 min. Samples were heat-
treated (4 min at 100 °C) to inactivate proteolytic enzyme activity (13) and centrifuged, 
and the supernatant was used for soluble iron and bioavailability experiments. 
Lactic Acid Addition. To determine the effect of lactic acid addition on iron 
solubility and bioavailability, 6 mg/g lactic acid was added to arepa, tortilla, and porridge 
prior to in vitro digestion. This acidification level was chosen on the basis of reported 
values of maize products fermented over 24 h (14). 
Cell Culture for Iron Bioavailability. All reagents for cell culture work were 
from Sigma Aldrich or Gibco BRL (Grand Island, NY) unless otherwise mentioned. The 
following experiments were conducted in Caco-2 cells at passages 31-36 using the 
previously described method (12). Cells were grown in a culture flask with Dulbecco’s 
Modified Eagle’s Medium (DMEM) with 10% fetal bovine serum, 1% v/v nonessential 
amino acids, and 1% v/v antibiotic-antimycotic solution. Cells were maintained at 37 °C 
in an incubator with 5% CO2. Trypsinized cells were seeded to collagenized (type 1 rat 
tail collagen) 12-well cell culture plates (Corning Costar) at a density of 5 x 104 cells/cm2 
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for iron bioavailability experiments. The plates were maintained at 37 °C and 5% CO2. 
Iron bioavailability experiments were conducted 15 days postseeding after a rinse with 
Earle’s Balanced Salt Solution. Serum free medium was prepared with DMEM with 1% 
v/v nonessential amino acids, 1% v/v antibiotic-antimycotic solution, 10 mmol/L 
piperazine-N,N-bis[2-ethanesulfonic acid] (PIPES), hydrocortisone (4 mg/L), insulin (5 
mg/L), selenium (5 ug/L), triiodothyronine (34 ug/L), and epidermal growth factor (20 
ug/L), as modified from Glahn et al. (15). Serum-free medium (0.5 mL) and 0.5 mL of 
the supernatant of each digest were added to the cell culture well and incubated for 2 h. A 
subsequent 0.5 mL of serum-free medium was added after the 2 h incubation, followed 
by further incubation for 22 h. After 24 h total of incubation, the samples were removed 
by aspiration from the cell culture wells, and the cells were rinsed with 1 mL of Earle’s 
Balanced Salt Solution. The cells were lysed in H2O by sonication. Total lysate protein 
was determined according to the Bradford Coomassie assay (Pierce Laboratories, 
Rockford, IL). Ferritin in the lysates was determined by using a radioimmunoassay kit 
(Fer-Iron II, Ramco Laboratories, Stafford, TX) and a Cobra-II gamma counter with 
SpectraWorks software (Packard BioSciences, Meriden, CT). After ferritin concentration 
is normalized to cell protein concentration, the values are expressed as relative 
bioavailability (RBA) as compared to porridge fortified with FeSO4. 
Iron Solubility. Supernatant from the in vitro digest was mixed 1:1 v/v with 20% 
w/v trichloroacetic acid in 6 mol/L HCl, incubated for 20 h at 65 °C, and then subjected 
to centrifugation at 5000g for 10 min (8). Iron in the supernatant was measured using the 
colorimetric method described under Iron Content. 
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Sensory Analysis. Because lactic acid addition may change the organoleptic 
characteristics of food, we conducted a sensory analysis on lactic acid added products. 
Differences between untreated and lactic acid treated samples were assessed by using the 
triangle test (16). The protocol was approved for exemption by the human subjects 
review committee at Iowa State University. The products were prepared using 
commercial mixes that best emulated the processed products prepared in the above 
sections, either with or without food grade lactic acid (6 mg of powdered lactic acid; 
Purac, Lincolnshire, IL). All products were prepared as per the manufacturers’ directions. 
Arepas (Harina PAN, Refinadora de Maiz Venezolana, C.A., Aragua, Venezuela) were 
shaped into cakes, 10 cm in diameter and 1 cm thick, and fried in a dry pan until crisp 
and browned both sides. Masa for tortillas (MASECA, Azteca Milling, City of 
Commerce, CA) was prepared, pressed in a tortilla press, and fried on both sides in a dry 
pan until the tortilla puffed with steam. Porridge (Bob’s Red Mill Cornmeal, Coarse 
Ground, Milwaukie, OR) was prepared by boiling cornmeal with H2O. Untrained 
panelists (44 total, 4 male and 40 female, ages 18-63) tested each of the three food 
products in a random sequence, receiving three samples (two identical, one different 
treatment). Ballots were scored for panelists’ ability to identify the product that was 
different.  
Statistical Analysis. Differences in iron and phytate content between processing 
steps and between with and without lactic acid treatment in the same food product were 
determined using Student’s t test. Differences in RBA and iron solubility among the 
processed products (grouped by fortification) were determined using ANOVA with 
Tukey’s multiple-comparison test. To assess the interactive effect of processing and 
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fortification, two-way ANOVA was used. Binomial probability distribution analysis was 
used for sensory analysis triangle test scores. All mean differences were deemed to be 
significant at p < 0.05. Analyses were performed using GraphPad software (GraphPad 
Prism version 4.02 for Windows, GraphPad Software, San Diego, CA), except for two-
way ANOVA, which was performed with SAS (SAS 9.0 for Windows, Cary, NC). 
 
Results and Discussion 
Changes in Iron Content during Processing. Iron content was found to not 
significantly change during processing except in arepa, where iron decreased 30.3% 
during decortication (p = 0.003), with a net decrease of 29.1% in the final product (p = 
0.002) (Figure 4.1). It was not surprising to see the decrease in iron content with the 
physical removal of bran and germ, as iron content is high in the germ and, to a lesser 
extent, in the bran layer. Defatted germ is reported to contain 36.7 mg/100 g (17) and 
2.79 mg/100 g for crude maize bran compared to 2.38 mg/100 g for whole maize (18). 
Because of a lack of waste streams, changes in iron content for porridge and ogi 
preparation were not significant. Because of the small weight of the waste stream in 
tortilla processing (neyajote), there was a negligible impact on iron content. Iron losses in 
steep water are low during nixtamilization because iron solubility is low due to the high 
pH associated with alkali treatment. However, in most traditional tortilla processes, the 
bran and germ layer are removed post-steeping, which should correspond to iron losses 
similar to decortication. 
Changes in Phytate Content during Processing. The total phytate content of 
maize products was significantly affected by fermentation in ogi preparation (-25.3%, p = 
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0.002) and decortication in arepa preparation (-34.5%, p = 0.01) (Figure 4.1); however, 
only arepa and tortilla showed a significant net decrease of phytate compared to the 
starting material (-25.6%, p = 0.003, and -16.6%, p = 0.02, respectively). Decortication 
would physically decrease the phytate content due to bran and germ removal, whereas 
fermentation would induce phytase activity. Fermentation, soaking, and germination are 
known to induce both endogenous phytases in seeds and exogenous phytases from 
microbial sources (19). Because endogenous phytase activity is low in maize [9 mIU/g as 
compared to 440 mIU/g for triticale (20)], phytate reduction in ogi is likely due to the 
microflora growth during fermentation.  
More successful reductions in maize phytate have been seen from the addition of 
exogenous phytase from other sources, including the use of bacterial phytase (99.2%) 
(21), wheat phytase (88%), and germinated sorghum (72%) (22). Phytate was shown to 
be reduced 42% in fermented maize gruel and 60 and 98% in fermented maize gruel with 
10 or 50 mg of wheat phytase, respectively (8). A 60% reduction in maize phytate after 
96 h of germination at 32 °C was shown (23), but this level of reduction may have a 
minimal impact in improving iron bioavailability (21, 24). Whereas germination has been 
implicated in reducing phytate content in maize porridges (25), the changes in starch 
functionality may limit its practical application in other maize products (arepa and 
tortilla).  
Heating primarily reduced the phytate content of tortillas (11.7%, p = 0.07) but 
did not affect other maize products. The differences might be due to the higher heat 
achieved in dry heating in the tortilla preparation. The reduction of phytic acid content 
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varies in the nixtamalization process on the basis of the conditions, such as alkali 
concentration, steeping time, and temperature (7).  
It has been suggested that phytate has to be reduced by >90% to see a 2-fold 
improvement in iron bioavailability (21). The phytate to iron molar ratio in all of the 
unfortified and fortified products is high, ranging from 17 to 30 for unfortified products 
and from 4.9 to 6.8 in fortified products (Table 4.1). It has been shown that the phytate to 
iron molar ratio should be <1, and preferably 0.4, to observe a significant increase in 
bioavailability (26). None of our products achieved this low ratio. 
Iron Solubility and Bioavailability. To compare the iron bioavailability of all 
maize products, results were normalized to porridge with FeSO4 values and referred to as 
RBA. The bioavailability of unfortified maize products was low as compared to fortified 
maize products, ranging from 37 ± 13 to 46 ± 16% RBA (Figure 4.2). As iron content 
could not logically be matched between fortified and unfortified products, these data 
should be interpreted with caution; however, they serve to show the net improvement in 
RBA with fortification.  
As anticipated, on average, the bioavailability of fortified products is about 2-fold 
higher than that of their unfortified counterparts except ogi with FeSO4, which was 6.6-
fold higher (RBA of 37 ± 13 versus 245 ± 16%). When FeSO4 fortified products were 
compared, the RBA of ogi was 2.5-fold higher than those of the other products (RBA of 
96 ± 6, 92 ± 11, and 100 ± 4% for tortillas, arepas, and porridge, respectively) (p < 
0.001). When products were fortified with RedFe, the RBA values of ogi (142 ± 6%) and 
porridge (111 ± 6%) were higher than those of tortilla (79 ± 6%) and arepa (84 ± 6% (p < 
0.001 and p < 0.01 for ogi and porridge, respectively).  
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The increase in iron bioavailability in ogi cannot be solely attributed to phytate 
reduction, as phytate levels were similar across all products, but can be attributed to 
increased iron solubility due to the acidic food matrix developed during lactic acid 
fermentation. Increased iron solubility was reported in various other lactic acid fermented 
products (8, 27-31), with the assumption that high-soluble-iron foods have higher 
bioavailability.  
When the bioavailability data were analyzed with two-way ANOVA, both 
fortificant (p < 0.0001) and product (p = 0.0158) had a significant effect on iron 
bioavailability. A significant interaction between fortificant and product was also 
observed (p = 0.008). The effect of fortificant was not surprising, as it is well-known that 
FeSO4 has high bioavailability as compared to RedFe (32, 33); however, the strong effect 
of product indicates a processing and food matrix effect on bioavailability. Our results 
suggest that choosing optimal fortification and processing techniques is important to 
achieve significant improvement in iron bioavailability. The iron bioavailability of ogi is 
higher than that of other maize products, suggesting that manipulation of the food matrix 
is an important strategy to enhance iron bioavailability in other products. Given the lactic 
acid production during the fermentation in ogi, it is feasible to add lactic acid to other 
products without further changing the processing conditions. 
Overall, addition of lactic acid to unfermented products increased bioavailability 
on average 1.7-fold (Figure 4.3). In the unfortified products, tortilla had an increase of 
2.1-fold (p < 0.01) and porridge and increase of 1.8-fold (p < 0.0001) with lactic acid 
addition. In FeSO4-fortified products, RBA increased 2.0-fold in tortillas (p < 0.001), 
whereas in products with RedFe, the RBA increased 2.1-fold in tortillas (p < 0.0001) and 
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1.7- fold in arepas (p < 0.0001). Regardless of fortification, the RBA of tortilla was 
improved with lactic acid addition. Given the low iron solubility of tortillas as compared 
to other products (Table 4.2), much of this improvement in bioavailability is likely 
attributed to the increase of iron solubility accompanying the acidification; however, it 
cannot be solely attributed to iron solubility. The low solubility of iron in all of the 
tortilla products is likely due to the high pH attributed to the alkali treatment during 
processing. As expected, the pH of the tortillas (pH 7.8) was higher than those of arepa 
and porridge (both pH 6.1) and ogi (pH 4.0). The addition of lactic acid to arepa and 
porridge reduced the pH to 3.9-4.1 and 4.6 with tortillas (data not shown). As shown in 
Table 4.2, lactic acid addition significantly improved iron solubility in tortillas (p < 
0.001), regardless of fortification, but not in the other products, suggesting the 
importance of an acidic environment on iron solubility and bioavailability. 
Lactic acid has been shown to enhance iron bioavailability through an enhancing 
effect on ferric iron transport across the intestinal epithelium (34), suggesting its 
effectiveness is greater with ferric than ferrous iron. Our results, showing greater 
effectiveness of lactic acid in arepa fortified with RedFe as compared to FeSO4, support 
the previous study. The effect of lactic acid on improving bioavailability in maize food 
products is most likely from two different effects: pH reduction preventing the formation 
of insoluble oxides, most evidently observed in high-pH foods (tortillas) and, to a lesser 
extent, enhancement of absorption of ferric iron because the enhancement was less with 
moderate-pH foods (arepa and porridge). Given the very high phytate level in the 
porridge, acidification may have been insufficient to overcome the phytate inhibition in 
porridge.  
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Effect of Lactic Acid on Organoleptic Characteristics. Untrained panelists 
were capable of detecting a difference in organoleptic characteristics between lactic acid 
and typical porridges (p < 0.0001); however, they were not capable of detecting a 
difference in tortillas (p = 0.166) and arepas (p = 0.831). These results are summarized in 
Table 4.3.  
Consumer testing suggested that the levels of lactic acid we used to improve iron 
bioavailability may not affect product quality except for porridge. The study was, 
however, limited, in that the consumer population is not a typical maize foods consuming 
population. It is possible that a maize-consuming population may be more sensitive to 
changes in formulation. On the other hand, the foods in this study were presented without 
any of the traditional seasonings and accompaniments that may act to mask off-flavors. 
At the household level, the addition of lactic acid culture or acid steeps may be a 
useful technique in certain product formulations. In addition, given the availability of 
powdered lactic acid, flours could be supplied with added lactic acid. This may be a cost-
effective means to increase the bioavailability of low-bioavailable fortificants such as 
RedFe rather than including high-cost, high-bioavailable fortificants. However, long-term 
storage studies would be necessary to evaluate the impact on nutrient stability and 
organoleptic acceptability of lactic acid enhanced maize products. 
This study supports the premise that fortification alone is not sufficient to improve 
iron status in populations; rather, an effort to improve the bioavailability of traditional 
foods using appropriate technology is necessary for successful fortification strategies. 
 
Conclusion  
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The effects of processing on iron bioavailability in maize are significant, 
especially with fermentation increasing bioavailability. The enhancing effect of 
fermentation may be attributed mostly to acidification from natural lactic acid production 
rather than phytate reduction. Lactic acid addition greatly improved iron bioavailability 
of low-bioavailable maize products, especially tortillas, without affecting organoleptic 
quality. The role of lactic acid and fermentation may have a beneficial impact on current 
iron fortification schemes, increasing iron solubility and bioavailability. Hence, the 
addition of lactic acid may be a novel means to increase the iron bioavailability of maize 
products. 
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Figure 4.2. Relative bioavailability [RBA (ferritin per milligram of cell protein) 
normalized to porridge with FeSO4] of maize products without fortification 
(no fort) or fortified with ferrous sulfate (FeSO4) or reduced iron (RedFe). 
Tort, tortilla; Arp, arepa; Por, porridge. Columns with stars are significantly 
different within similarly fortified products as determined by ANOVA with 
Tukey’s multiple-comparison test: *, p < 0.05; **, p < 0.001; n = 9-14. 
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Figure 4.3. Relative bioavailability ratios [RBA (ferritin per milligram of cell 
protein) normalized to porridge with FeSO4] of products with or without 
added lactic acid (+LA/-LA). Dotted line represents no effect of LA. Tort, 
tortilla; Arp, arepa; Por, porridge; RedFe, reduced iron. Student’s t test 
was used to compare RBA of +LA and –LA products: *, p < 0.01; **, p 
< 0.001; ***, p < 0.0001; n = 5-14. 
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Tables 
Table 4.1. Phytate to Iron Molar Ratios for maize products 
  Tortilla Arepa Ogi Porridge 
No fortification 17.1 ± 1.3 20.7 ± 3.0 21.9 ± 2.6 30.0 ± 6.9 
With fortification 4.9 ± 0.3 5.1 ± 0.6 5.6 ± 0.4 6.8 ± 0.7 
Mean ± SD, n =4-8. 
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Table 4.2. Percent soluble iron in processed maize products following in vitro digestion 
  Tortilla Arepa Ogi Porridge 
No fortification -0.7 ± 0.9a 6.7 ± 2.6ab 14.9 ± 2.4b  7.1 ± 4.3 b 
+ lactic acid 18.4 ± 0.5** a 26.8 ± 2.0** b   24.7 ± 0.5* b 
+ FeSO4 -0.6 ± 0.2 a 30.6 ± 0.6 c 21.2 ± 1.5 b 28.4 ± 1.5c 
+ FeSO4 + lactic acid 3.9 ± 0.1** a 27.4 ± 2.2 b   25.6 ± 1.3 b 
+ Red Fe -0.6 ± 0.2 a 14.6 ± 0.6 b 13.8 ± 2.0 b 14.3 ± 0.4 b 
+ Red Fe + lactic acid 6.5 ± 0.9** a 13.6 ± 1.5 b   12.7 ± 0.6 b 
%soluble iron is expressed relative to total iron in the sample. Mean ± SD, n = 4-8. 
Difference among processing treatments was determined by ANOVA with Tukey’s 
Multiple comparison.  Means in the same row with the same superscript are not 
significantly different.  Lactic acid effect for each fortificant and treatment was 
determined individually by Student’s t test, * p < 0.01, ** p < 0.001. 
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Table 4.3. Number of respondents able to correctly differentiate lactic acid added 
products from typical products using triangle testing  
  p value*
Arepa 14 / 44 0.831
Tortilla 19 / 44 0.166
Porridge 32 / 43 <0.0001
 *Binomial probability distribution 
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Overexpression of Zea mays Hemoglobin in maize endosperm tissue can 
increase iron bioavailability 
Intended to be published in Journal of Nutrition upon evaluation of the F2 maize. 
 
Abstract 
Biofortification has been suggested as a novel means to improve iron content or 
bioavailability in staple crops.  Maize is a staple crop in many parts of the world but the 
bioavailability is low due to its high phytate content.  Our hypothesis is that through over-
expression of the Zea mays hemoglobin (ZmHb) gene in maize endosperm we can deliver 
iron in a highly bioavailable form, and circumvent the inhibitory effect of phytate.  A 
gene construct was developed by transcriptionally fusing ZmHb to the translational 
fusion product of Zea mays 27 zein promoter with a green fluorescent protein (GFP). 
This construct was stably transformed into maize, and F1 seeds were evaluated for the 
presence of ZmHb and GFP by immunoassay, for the presence of heme pyrrole 
incorporation by chemilluminescence, and analysed for iron bioavailability using the 
Caco-2 cell culture model.  Expression of ZmHb-GFP fusion product was confirmed by 
using separate ZmHb and GFP antibodies.  Two lines, P65 and P26 that are positive for 
ZmHb and GFP, expresssed 4.2 and 4.9 ug ZmHb / g seed, respectively.  Line P26 (p < 
0.001) had 125% and line P65 had 68% (p < 0.01) higher iron bioavailability than HiII, 
the untransformed line.  These preliminary studies suggest that ZmHb overexpression in 
endosperm may be a successful strategy to significantly increase bioavailable iron in 
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maize.  Future studies with animal models using later generations of seeds are necessary 
to confirm these results.  
 
Introduction 
Iron deficiency has been long identified as the most prevalent nutrient deficiency 
worldwide (Stolzfus, 2003).  Despite a variety of efforts and international mandates for 
reductions of iron deficiency, minimal progress has been made because of the diverse 
challenges.  Alleviating iron deficiency can improve health, wellbeing (Zimmerman and 
Hurrell, 2007) and economic status (Horton, 2006) but challenges do exist in 
implementing iron supplementation and fortification programs in some of the most 
isolated and resource poor regions of the world where iron deficiency is most prevalent.  
Maize is a common staple crop in many developing countries where iron deficiency is 
very high, and is problematic nutritionally because of its high phytate content causing 
low iron bioavailability.  Fortification of maize has been only marginally successful, and 
processing-based strategies have had limited dissemination in low resource settings.  
Novel strategies are necessary to make a large impact on reduction of iron deficiency in 
populations consuming maize, and agronomic-based technologies may provide such a 
novel approach.  
Biofortification, the improvement of nutritional quality of staple crops by 
traditional and biotechnology based crop breeding, is considered a novel, cost efficient, 
and self perpetuating means of improving the nutritional quality of staple crops (Nestel et 
al, 2006).  Transgenic modification for improving iron bioavailability has been 
previously developed in several staple crops, including rice, and maize.  Transgenic rice 
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expressing soybean ferritin, when evaluated in a rat hemoglobin repletion model, had 
bioavailability similar to rice fortified with FeSO4 (Murray-Kolb et al, 2002).  Recently, 
rice expressing transgenic human lactoferrin bioavailability was also shown to be 
equivalent to FeSO4 fortified rice in young women (Lonnerdal and Bryant, 2006).   
Specifically referring to maize, several strategies have been explored for 
biofortification.  This has included screening of maize germplasm for high iron 
bioavailable lines (Oikeh et al, 2003) and identifying mutants with reduced phytate 
levels, designated as lpa for low phytic acid (Raboy, 2001).  These low phytate 
transformants have shown improve iron bioavailability from porridge and tortillas 
(Mendoza et al, 2001; Mendoza et al, 1998).  Maize which expressed both transgenic 
soybean ferritin and Aspergillus niger phytase also had significant increases of 
bioavailable iron (Drakakaki et al, 2005).   
There is a complex series of challenges to face with the previous strategies for 
improving maize iron bioavailability.  While low phytate maize has shown promising 
results with iron absorption, low yield of this maize (Raboy et al., 2000) and other 
negative effects on the seed (Pilu et al., 2005) limits its commercial production.   
Expression of human proteins in staple foods, as in the case of lactoferrin expressing rice, 
poses ethical challenges in incorporating foreign (in this case, human) genes.  This 
approach however may be useful for the development seed lines for pharmaceutical 
applications rather than open sourced seed for food use.  Merely increasing non-heme 
iron content, either as total iron, or as ferritin iron may not be effective, as the phytate 
content has to be significantly reduced by at least 90% to see a meaningful increase in 
iron absorption (Hurrell et al, 2003). 
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Hemoglobin iron absorption from animal sources is not affected by the dietary 
factors, icluding phytate ((Lynch et al, 1985).  Most plants also have genes coding for 
hemoglobin proteins (Kundu et al, 2003) and the hemoglobin genes in maize have been 
characterized (Arechaga-Ocampo et al, 2001).  Since we have shown in our earlier study 
that plant hemoglobin is as bioavailable as bovine hemoglobin (Proulx and Reddy, 2006), 
the role of plant hemoglobin for nutrition looks promising.  Overexpression of 
hemoglobin in the endosperm of maize through genetic modification may be ultimately 
possible to develop grain with highly available iron.  Our hypothesis is that through 
overexpression of the Zea mays hemoglobin gene in maize endosperm we can improve 
iron bioavailability by delivering iron in a highly bioavailable form, and circumventing 
the inhibitory effect of phytate.  Our ultimate goal would be to use only maize DNA 
sequences to produce this enhancement through intragenic recombination.   
 
Materials and Methods 
Construct Development 
All constructs were based on the original plasmid pAct1IsGFP-1 (Cho et al, 2000) 
which has the modified green fluorescent protein (GFP) gene sGFPs65T (Genbank 
accession #ABB59985) and nos terminator sequence (modified from Genbank accession 
V00087).  This plasmid was modified to include the promoter sequence from the 27 kDa 
gamma zein (27zn) (Genbank accession #EF061093) which was shown to produce high 
expression of GFP within maize endosperm tissue (Shepherd et al, 2007).  The cDNA for 
Zea mays hemoglobin (ZmHb) was obtained from the Iowa State University Expressed 
Sequence Tag Library (Genbank accession # BM333948).   
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For the construct used for maize transformation (Figure 5.1), a PCR product was 
amplified using Pfu polymerase (Stratagene, La Jolla CA) from the ZmHb EST (forward 
primer CGCCCTTCCATGGCACTCGCGGAGGCC; reverse 
CCATGGCATCGGGCTTCATCTCCC), and subcloned to pCR 2.1 Topo Vector 
(Invitrogen Corporation, Carlsbad CA) for amplification in E. coli XL1 Blue (Stratagene, 
La Jolla CA).  The ZmHb was restriction digested from pCR 2.1 vector by NcoI, and was 
inserted into the 27zn GFP vector at the NcoI restriction site such that ZmHb and GFP 
formed a gene fusion product (27zn ZmHb GFP nos).  The sequence of the construct was 
verified by DNA sequencing at the Iowa State University DNA facility prior to 
transformation.   
Stable Transformation 
Stable transformation of gene constructs into maize plants was accomplished at 
the Plant Transformation Facility at Iowa State University, by gold particle bombardment 
of HiII Type II callus (Frame et al, 2000).  Callus was bombarded with the plant 
hemoglobin expression vector (Figure 5.1), and cobombarded with a plasmid containing 
the bar gene for bialaphos resistance (Gordon-Kamm et al, 1990)  T0 callus was raised 
on bialaphos selective media, and resistant callus was screened for the presence of the 
gene of interest (27zn ZmHb GFP nos) by PCR using GoTaq (Promega, Madison, WI) 
(27zn ZmHb GFP nos – forward primer #1 
CCGATCGACACCATGGCACTCGCGGAG, reverse #1 
CTTGCTCACCATGGCATCGGGCTTCATC; forward primer #2 
GATGAAGCCCGATGCCATGGTGAGCAAG, reverse #2 
CTGCAGCCGGGCGGCCGCTTTACTTG). Transformed callus that was positive for 
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insertion of the construct was regenerated to plants in the Plant Transformation Facility 
Greenhouse, and crossed to the inbred B73 to create F1 kernels.   
ZmHb Antibody Production  
The coding sequence for ZmHb (Genbank accession #AY005818) was also 
inserted into a pET28 plasmid for expression in E. coli BL21 Star DE3 (Invitrogen 
Corporation, Carlsbad CA) so that the insertion resulted in a transcriptional fusion with a 
c-terminal 6x His tag.  The resulting protein was purified using metal affinity 
chromatography as previously described (Smagghe et al, 2006).  Purified transgenic 
ZmHb was utilized for polyclonal antibody production in rabbits (ProSci Incorporated, 
Poway, CA) for immunoassay based analyses described below. 
Screening Transgenic Maize Seed for GFP Expression: 
Every F1 seed, grouped by transformation event, from the 27zn ZmHb GFP nos 
transformation was screened for the presence of GFP.  The first screening was a visual 
evaluation of GFP expression.  This was accomplished by placing intact kernels 
endosperm up and germ down into a black 48 well cell culture plate, and measuring 
fluorescence with spectrofluorometer (Tecan, Mannedorf-Zurich, Switzerland) at 485 nm 
excitation and 535 nm emission wavelengths.  GFP positive seeds were selected by a 
combination of spectrofluorometer readings 4 times higher than the untransformed 
negative control, combined with a secondary manual screen conducted by visual 
inspection through an orange filter using a hand-held Dark Reader lamp (Clare Chemical 
Research Inc. Dolores, CO).    
Seeds that were positive for GFP were secondarily screened by immunoassay for 
the presence of both GFP and ZmHb.  Ground maize (50 mg) was suspended in 500 uL 
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of Lammeli buffer, boiled, centrifuged, and 15 uL supernatant loaded on 15% SDS-
PAGE gels.  Separated proteins were then transferred to a nitrocellulose membrane, 
blocked overnight with 5% milk in Tris Buffered Saline with Tween (TBST).  
Membranes were probed for 3h either with anti-GFP monoclonal antibody (Living 
Colors, Clontech, Mountain View, CA), or with anti-ZmHb polyclonal antibody 
(described above) with 1:25,000 dilution in 2% milk in TBST.  Membranes were then 
probed for 1h with either goat anti-rabbit or goat anti-mouse antibody conjugated with 
horseradish peroxidase, both diluted 1:50,000 in 2% milk in TBST.  Immunoreactive 
bands were visualized by chemilluminescence and abundance of GFP and ZmHb proteins 
was estimated by densitometry (QuantOne, Biorad, Hercules CA) against purified 
recombinant ZmHb standard or GFP standard (Clontech, Mountain View, CA, USA).   
Measurement of the incorporation of the iron pyrrole into the transgenic ZmHb 
was accomplished using the pseudoperoxidase capacity of iron associated with the heme 
pyrrole, coupled with luminol based chemilluminescence, modified from Bonfils et al, 
(1995).  Briefly, 200 mg of ground maize, positive for ZmHb based on immunoassay, 
was extracted for 30 min with shaking in 1 mL 100 mM Tris, pH 6.8, and centrifuged.  
The supernatant was concentrated by ultrafiltration through a 10,000 MWCO filtration 
device (Millipore Ultrafree MC), then the entire filter retentate (50 uL ± 5 uL) was mixed 
with 200 uL of luminol buffer (1mL 0.1 mol/L luminol, 1 mL 0.02 mol/L 4-iodophenol, 
and 20 uL 30% hydrogen peroxide in 50 mL phosphate buffered saline, pH 7.4).  
Chemilluminescence was measured (Synergy 4, BioTek, Winooski VT) and heme iron 
concentrations were estimated by comparing with hemoglobin standards using log-log 
curve fitting.   
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Iron Content  
Total iron content in maize was measured using the modified AOAC method 
944.02.  Briefly, 0.1 g of sample was mixed with 2.0 mL nitric acid and ashed at 250 W 
in a microwave digester (Milestone Sci, Shelton, CT) until the resulting liquid was clear. 
The digested sample was diluted to 5 mL with deionized H2O.  Iron content was 
measured as described previously (Proulx and Reddy, 2006) using ferrozine (3-(2-
Pyridyl)-5,6-diphenyl-1,2,4-triazine-4′,4′′-disulfonic acid Sodium salt) and measuring 
absorbance at 562 nm in a microplate reader.    
In Vitro Digestion 
Maize samples were prepared for bioavailability assessment using the method 
described by Glahn et al 1998 and Proulx and Reddy, 2006.  Maize samples (0.5 g) were 
mixed with 0.7 mL deionized water, 1.0 mL of 0.1 mol/L HCl, and adjusted to pH 2.0 
with 1.mol/L HCl.  Pepsin solution (0.2 mL of 0.2 g porcine pepsin A (1:60000) in 10 
mL 0.1 mol/L HCl) was added, and the sample was incubated at 37° C with shaking (500 
rpm) to mimic gastric digestion.  The pH was then adjusted to 6 with 1 mol/L sodium 
bicarbonate, and 0.715 mL of pancreatin and bile solution was added (0.05 g porcine 
pancreatin (4xUSP) and 0.3 g bile extract in 25 mL of 0.1 mol/L sodium bicarbonate 
solution).  To mimic duodenal digestion, the samples were again incubated at 37° C with 
shaking for 15 min. The digests were heat treated for 4 min at 100° C to inactivate 
proteolytic activity as suggested previously (Jovani et al, 2001) and centrifuged at 5000 x 
g for 10 min.  The resulting supernatant was used for measuring bioavailable iron. 
 
Iron Bioavailability in Caco-2 Cells 
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All reagents for cell culture work were from Sigma Aldrich (St Louis MO) or 
Gibco BRL (Grand Island NY) unless otherwise mentioned. 
Caco-2 cells were obtained at passage 17 from American Type Culture Collection 
(Rockville, MD).  The following experiments were conducted with cell passages 23-26 as 
described by Proulx and Reddy (2007).  Cells were grown in a culture flask with 
Dulbecco’s Modified Eagle’s Medium (DMEM) with 10 % fetal bovine serum (FBS), 1 
% v/v nonessential amino acids and 1% v/v antibiotic-antimycotic solution.  Cells were 
maintained at 37° C in an incubator with 5 % CO2.  Media was changed 3 times weekly.  
At 7 d, the cells were rinsed with Earle’s Balanced Salt Solution (EBSS), trypsinised to 
dissociate the cells, and centrifuged at 22.6 x g.  The cells were seeded at a density of 5.6 
x 103 cells/cm2 in a 75cm2 culture flask for continued growth, or seeded on collagenized 
(Type 1 Rat tail collagen) 48 well cell culture plates (Corning Costar) at a density of 5 x 
104 cells/cm2 for iron bioavailability experiments.  The cell culture plates were 
maintained at 37° C and 5 % CO2.  Iron bioavailability experiments were conducted 15 d 
post seeding after rinsing the cell monolayer with EBSS.  Serum free media, prepared 
with DMEM with 1 % v/v nonessential amino acids, 1 % v/v antibiotic-antimycotic 
solution, 10 mmol/L PIPES (piperazine-N,N'-bis-[2-ethanesulfonic acid]), hydrocortisone 
(4 mg/L), insulin (5 mg/L), selenium (5 µg/L), triiodothyronine (34 µg/L) and epidermal 
growth factor (20 µg/L) (Glahn et al, 1998), was used during cell iron uptake.  Serum free 
media (0.125 mL) and 0.125 mL of the supernatant of each digest were added to the cell 
culture well, and incubated for 2 h.  A subsequent 0.125 mL serum free media was added 
after the 2 h incubation, followed by a further incubation for 22 h.  After 24 h total 
incubation, the samples were removed by aspiration from the cell culture wells, and cells 
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rinsed with 0.25 mL EBSS.  The cells were then lysed by addition of 0.125 mL deionised 
water to each well, and sonicated with a probe-type sonic dismembranator at lowest 
setting (< 1 W output) for 15 s.  Total cellular protein was determined in the lysates by 
the Bradford Coomassie Assay, (Pierce Laboratories, Rockford Illinois).  Ferritin in the 
lysates was determined by radioimmunoassay (Fer-Iron II, Ramco Laboratories, Stafford 
TX), and measured using a Cobra-II gamma counter with SpectraWorks software 
(Packard BioSciences, Meriden CT).  Ferritin concentration was normalized to cell 
protein concentration as well as corrected for differences in iron content and expressed as 
relative biological availability (RBA) of the control line, HiII.   
Statistical Analysis 
All maize sample analyses were performed in 2 replicates, except for 
bioavailability measurements in which were analysed in 3 replicates.  The samples were 
analysed in 3 repeated measures, except for bioavailability.  Five to six repeated 
measurements were carried out on each replicate for assessing cell iron bioavailability.  
Differences among the treatments were determined using one way ANOVA with Tukey’s 
post hoc testing (GraphPad Prism 4.0, San Diego, CA).   
 
Results 
Construct Building and Plant Transformation 
The construct developed for transformation incorporated the 27 kDa gamma zein 
promoter previously cloned from the maize inbred Va26 (Shepherd et al, 2007).  The use 
of this promoter was based on its previous evidence showing good protein expression and 
tissue specificity within maize endosperm.  The 27 kDa gamma zein promoter was 
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transcriptionally fused to the ZmHb coding sequence, which was translationally fused to 
GFP by elimination of the stop codon within the ZmHb gene.  The predicted fusion 
protein product would have a molecular weight of 40 kDa, 15kDa contributed from 
ZmHb and 25kDa contributed by GFP as shown in Figure 5.2, and this molecular weight 
was confirmed by SDS-PAGE combined with an immunoassay (Figure 5.3).  In the 
transformed maize we were not able to detect the ZmHb fusion product because a native 
protein in high abundance is also 40kDa (Figure 5.2).  Because of the ubiquitous nature 
of heme compounds within cells, it was assumed that the ferrochelatase activity required 
for heme pyrrole insertion into the expressed ZmHb would be accomplished without need 
of further genetic modification, and this was evaluated in the chemilluminescent assay 
results described below.  The Nos terminator was chosen because of its common use in 
biotechnology based applications. 
Eighty bialophos resistant callus transformation events were screened for the 
presence of transgene DNA by PCR.  The primer sets selected were designed to identify 
the artificial sequence arrangement between the ZmHb coding sequence and the 27 zein 
promoter, as both are originally derived from maize genetic code.  The first primer set 
covered the region where the 27 zein promoter was fused to the ZmHb coding sequence, 
through the coding region where ZmHb and GFP were translationally fused.  The second 
primer set covered the ZmHb and GFP fusion region through to the end of the GFP 
coding region, thereby identifying only synthetic regions of DNA.  This approach 
eliminated any ambiguity that may have arisen from amplification of native ZmHb or 27 
zein promoter code.   
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Of the 80 calli screened, 20 were positive for both regions of the construct.  The 
transgene-positive calli were regenerated to plants which were used to pollinate the non-
transgenic inbred line B73 to produce F1 seeds.  Fifteen out of 20 transformation events 
were positive for GFP, implying that as a fusion product, ZmHb should also be 
expressed.  Given the small number of seeds available in the F1 generation, two lines 
with containing sufficient  number of seeds were selected for further analysis.  These 
lines are referred to as P26 and P65. 
Seed Screening 
Whole ground seeds were analysed for the presence of GFP and ZmHb proteins 
by western blot immunoassays.  Both transgenic lines accumulated a product of 
approximately 40 kDa, approximately the estimated molecular weight of the ZmHb-GFP 
fusion product.  This product reacted both with antibodies specific for GFP and ZmHb 
(Figure 5.3).  There was no cross-reactivity of the ZmHb antibody against untransformed 
lines, B73 and HiII suggesting low concentration of native Hb concentrations in maize.  
Densitometry of the immunoassay using the ZmHb antibody indicates that the 
concentration of the fusion protein was approximately 4.2 ug ZmHb per g maize in line 
P26, and 4.9 ug per g of maize in line P65.  The GFP was expressed at approximately 
25.7 ug and 36.7 ug per g maize in P26 and P65, respectively as per the immunoassay.  
This suggests a molar ratio of ZmHb to GFP in line P26 of 1:3.6, and in line P65 a ratio 
of 1:4.5.    
To ensure that expressed ZmHb accumulated heme pyrrole, we made an attempt 
to quantitate heme pyrrole with chemilluminescence in two transgenic maize lines.    
 110
The transgenic line P26 had 6.8 µg Hb /g in the seed, which was higher than the HiII 
seeds (p<0.001), whereas line P65 was not distinguishable from untransformed HiII.  
This may indicate that despite the presence of the heme protein, incorporation of the 
heme pyrrole does not occur in all transgenic lines.   
Iron Bioavailability 
In the Caco-2 bioavailability assay, significant variation among the samples was 
observed.  The bioavailabilty was assessed as ferritin response to the digests, normalized 
to total cell protein.  Since the iron content was varied among the seeds (33.4 ug/g in 
HiII, 20.4 ug/g in P26 and 23.1 ug/g in P65), ferritin values were further corrected to iron 
content of the seeds (Figure 5.4).  Mean bioavailability values for the two transgenic 
lines and the non-transgenic hybrid HiII were significantly different.  P26 had 125% 
higher bioavailability than HiII (0.95 ± 0.08 vs 0.42 ± 0.02 (ng ferritin/ug protein)/(mg 
Fe/g maize) p < 0.001).  The measure of bioavailability was based on the standard ferritin 
versus cellular protein content normalized to the iron content of the maize.  The P65 line 
had 0.67 ± 0.05 (ng ferritin/ug protein/mg Fe, which was 68% higher than HiII (p < 
0.01).   
 
Discussion 
Maize has a significant amount of phytate, which is a potent inhibitor of iron 
absorption.  Even by doubling the quantity of iron in maize, there is ample phytate to 
radically inhibit most iron absorption.  Thus it is important to develop other strategies 
that improve iron bioavailability rather than merely increasing iron content.  The strategy 
of overexpressing ferritin has received attention recently because plant ferritins have 
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shown absorption as high as FeS04 in rat models (Murray-Kolb et al, 2002) and in human 
models (Lonnerdal et al, 2006).  However it is now understood that ferritin is degraded 
during digestion and iron associated with the protein will enter the common non heme 
iron pool, thus making it susceptible to phytate inhibition (Bejjani et al, 2007).   
Unlike ferritin, hemoglobin is highly bioavailable iron source with a unique 
uptake pathway and transport mechanisms (Shayeghi et al, 2005).  The clathrate-type 
structure around the iron is protective against the inhibitory effects of phytate and other 
non-heme iron inhibitors (Lynch et al, 1985).  Therefore, expressing hemoglobin in 
plants is a novel strategy for biofortification.  However, ethical reasons of using animal 
proteins in plants and also foreign gene affecting plant growth.  Results of our previous 
study showed soy and bovine hemoglobins have similar bioavailability (Proulx and 
Reddy, 2006), suggesting that plant hemoglobins could be useful candidates for 
biofortification  and could confer nutritional advantages of heme iron to plant foods.  But 
secondly, by using plant based genetics, and in particular strategies involving only 
intragenic recombination, novel nutritionally enhanced staples such as maize could be 
developed without introduction of transgenic material. 
The functional role of hemoglobin in plants is not completely certain, however it 
has been postulated to be either for gas binding to facilitate metabolism, to interact with 
other organic molecules to facilitate transport or synthesis, or to scavenge oxygen within 
cells (Arredondo-Peter et al, 1998).  In leguminous plants, such as soybeans, the 
predominant hemoglobins are classified as symbiotic because of their exclusive 
expression by the plant in the presence of nitrogen fixing bacteria, facilitating a lower 
oxygen concentration for increased functionality of nitrogenase enzyme (Wittenberg et 
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al, 1975).  In non-leguminous plants, the physiological function of hemoglobins is not 
well understood, and may be part of a stress-response mechanism, as mRNA transcripts 
and expression of hemoglobin protein increase under hypoxia (Taylor et al, 1994).  A few 
studies evaluate transgenic expression of maize hemoglobins and their role in physiology, 
again suggesting a role in nitric oxide metabolism (Dordas et al, 2004) and hypoxia 
(Sowa et al, 1998).  No studies of maize hemoglobin have been conducted in nutritional 
studies. 
The use of the GFP fusion in the construct presented was specifically to facilitate 
easy visual screening in the first attempts to overexpress hemoglobin in maize 
endosperm.  GFP is easy to detect using visual screening.  Given the assumption that 
expression of GFP would be coupled to the expression of the ZmHb by the fusion of the 
gene sequences, a screening methodology for ZmHb could then be developed for 
utilization in future plant transformations overexpressing ZmHb without the GFP.  It was 
unexpected that the molar ration of GFP to ZmHb was not 1:1, however immunoblotting 
is not an ideal quantitative method, suggesting that the error may be methodological.   
Attempts to find native ZmHb in untransformed seed and seedling tissues showed 
no cross reactivity against the antibody developed, suggesting that either the antibody is 
specific to only overexpressed ZmHb or the native hemoglobin is not in detectable 
concentrations.  The ZmHb presumed expressed in plant tissues were neither detected in 
roots, stems or leaves of 14d seedlings when exposed to 48h of oxygen reduced 
environment, or 250 mM NaCl (data not shown).  When attempting to identify the band 
for expression of the ZmHb-GFP fusion product, it similarly was not identified in the 
 113
SDS-PAGE gel (Figure 5.2), suggesting the protein expression level is very low in the 
transgenic crop. 
In the construct developed, it is assumed that there is heme pyrrole incorporation 
into the protein based on previous transgenic expression studies showing that 
mechanisms for heme incorporation into the globin protein was spontaneous and not 
requiring overexpression of enzymes responsible for heme synthesis (Smagghe et al, 
2006).  Secondly it is assumed that cytoplasmic accumulation of the protein would be 
sufficient for heme pyrrole incorporation based on evidence that Arabidopsis thaliana 
hemoglobin expression is targeted to the cytosol (Hebelstrup et al, 2007).   
The chemilluminescent assay developed for evaluation of heme iron incorporation 
is based on the Fenton reaction where iron reacts with hydrogen peroxide forming 
hydroxyl radical, which catalyses the chemilluminescent reaction.  Although we assumed 
that the catalytic activity comes from iron incorporated into ZmHb, other metalloproteins 
such as ferritin or low molecular weight iron, such as that bound to phytate, or in free 
ionic form could also catalyse this reaction.  However, by using the 10,000 MWCO 
ultrafiltration device, we would have eliminated low molecular weight iron binding 
components which would have been eluted in the concentration process.  The assay could 
be refined to sieve out other metaloproteins larger than ZmHb by using a two-stage 
molecular weight cutoff ultrafiltration,.   
With the expression of 4.2-68 µg ZmHb/g maize in P26, and 4.9 µg ZmHb/g 
maize in P65, we can expect 1.6-2.5 µg Fe from heme per 100g serving of maize, given a 
1:1 molar ratio of iron atom to 15 kDa protein.  While the amount appears to be a small, 
we suspect that GFP may be interfering with the heme iron incorporation into the protein.  
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It is promising that the transformed line with confirmed heme incorporation (P26) had 
higher bioavailability than the P65 line.  It is possible that this difference is due to 
environmental effects or differences in genetic background.  Although HiII was the same 
genotype that was transformed, and used for comparison basis in this study, this genotype 
does not breed true because it is a hybrid.  Thus, comparisons to this genotype are 
somewhat risky.  We chose only two transformed lines in this study to assess iron 
accumulation and bioavailability based on the largest amount seed available for the assay 
rather than highest levels of ZmHb or GFP or based on how many copies of the gene 
construct were inserted.  More definite conclusions can be made once we conduct studies 
when more seeds are available in the F2 generation..  
Subcellular localization of the ZmHb protein within the endosperm was not 
investigated in this study.  The localization of recombinant proteins in endosperm has 
been shown important for maximal protein functionality, and for minimization of 
unknown effects on other components within the seed (Drakakaki et al, 2006).  It is 
known that the presence of transgenic hemoglobin can have significant effects on plant 
growth and can alter concentrations of a wide variety of metabolites (Holmberg et al, 
1997).  Compartmentalization for greater protein stability, however, may compromise 
heme pyrrole incorporation.  In the case of ZmHb overexpression, while it is assumed 
that cytosolic expression is adequate, appropriate targeting may permit higher expression 
levels, or greater heme pyrrole insertion.  It is suggested that the enzymes in plants 
responsible for heme synthesis and the insertion of iron into heme pyrroles are associated 
with the mitochondria and chloroplasts (Van-Lis et al, 2005; Masuda et al, 2003).  It is 
not currently clear where heme pyrrole insertion into apohemoglobin takes place.   
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As mentioned, the data presented is preliminary, with a larger data set comprising 
8 transformation events will be developed upon regeneration of F2 maize lines.  By 
increasing the number of lines evaluated, and by increasing the sample size, the quality of 
the analysis will improve.  With a very small sample size, seed to seed variation can play 
a highly significant effect on results.  And with more transformed lines to select from, the 
best breeding material can be selected for future studies and applications.   
Much interest has been recently placed on stacking traits to capitalize on 
synergistic improvements in crop quality.  It could be possible in the future to cross 
maize lines which have different iron bioavailability enhancements, such as 
overexpressed ZmHb or ferritin, and low phytate mutants.  There may also be interest in 
enhancing iron uptake regardless of targeting to a specific metalloprotein.  This could be 
accomplished through manipulation of iron metabolic pathways, such as incorporation of 
muagenic acid, ferric reductase, or yellow stripe 1 mutants into the breeding lines. 
It is the long term goal of this research to develop maize lines overexpressing 
ZmHb using only maize DNA.  Given the development of maize lines utilizing the 27zn 
promoter, ZmHb, and Zein termination sequences all derived from maize genomic 
sequences, it will open a novel aspect of genetic breeding, and challenge regulatory 
definitions of genetic modification.  Recombination, rather than transgenic modification 
may have more consumer acceptance because of the use of only native genes.  Secondly, 
the strategy of eliminating transgenic material is important to eliminate the impact of 
GFP on protein synthesis and heme incorporation from the fusion product.  It is 
anticipated that the non-fused ZmHb may have a higher iron pyrrole incorporation and 
therefore higher bioavailability, as it would be a protein in the native state. 
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Conclusion 
Overexpression of Zea mays hemoglobin in the endosperm of maize has the 
potential to significantly increase the bioavailability of iron.  Further breeding efforts will 
aim to increase the quantity of bioavailable iron within the endosperm tissue, and aim to 
use only maize derived genetic materials, to broaden the potential nutritional impact of 
this crop.  
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Figure 5.1. Schematic drawing of construct 27zn ZmHb GFP nos developed for 
overexpression of Zea mays hemoglobin in maize endosperm. 
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Figure 5.2. SDS PAGE gel stained in Coomassie, showing similarity of whole kernel 
protein profiles across all analysed maize lines.  1. Biorad Broadrange Prestained Ladder 
(all molecular weights in kDa); 2. ZmHb expressed in E. coli; 3. GFP; 4. P2P284-26, 5 
P2P284-65, 6. untransformed HiII, 7. B73.   
ZmHb 
GFP 
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Figure 5.3. Western blot probing for GFP (A) and ZmHb (B) across all analysed maize 
lines.  For all maize samples, 15uL was loaded from 50mg maize suspended in 500uL 
Lammeli buffer.  Lane 1. Transgenic ZmHb from E. coli (30 ng); 2. GFP (20 ng); 3. 
P2P284-26 4, P2P284-65, 5;. untransformed HiII; 6. B73.   
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Figure 5.4. Iron bioavailability of genetically modified maize lines with Zea mays 
hemoglobin overexpression in endosperm.  Bioavailability termed as (ng ferritin / ug 
protein) normalized over mg Fe per g maize.  N=19 for P284-26, 23 for HiII, and 24 
for P284-65. Columns with different letters are significantly different (p<0.05) as per 
one way ANOVA with Tukey’s multiple comparison.  
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Appendix  
Materials and Methods not discussed in the Results section 
In the second construct (Figure 5.5-A), a second PCR product was amplified using Pfu 
polymerase from the ZmHb EST with addition of a 5’ NcoI (forward primer 
CGCCCTTCCATGGCACTCGCGGAGGCC; reverse 
CGCCCTTGCGGCCGCTACTAGGCATCGG), and subcloned to pCR 2.1 Topo Vector 
with amplification in E. coli XL1 Blue.  The ZmHb was restriction digested from pCR 
2.1 vector by NcoI and NotI.  The 27zn GFP vector was subjected to digestion with NcoI 
and partial digestion with NotI to remove the GFP gene.  ZmHb was ligated to the 
partially digested 27zn GFP vector to form the vector 27zn ZmHb nos.  This construct 
has been stably transformed and screened for the presence of the gene of interest in 
undifferentiated callus. 
 
The third construct (Figure 5.5-B) was developed using a putative zein terminator 
(Zntm) sequence determined from the 3’ region after the stop codon sequence in the 27 
gamma zein gene (Genbank Accession # X53514) and cloned by PCR using Pfu 
polymerase from genomic DNA from the Zea mays inbred line B73 (forward primer 
GCGGCCGCAAGAAACTATGTGCTGTAGTATAGCC; reverse 
GCGGCCGCAAGCTTAGCTTCAAGTCTTTAACT).  The PCR product was subcloned 
to pCR 2.1 Topo vector, and amplified in E. coli XL1 Blue.  The Zntm terminator 
sequence was digested from the pCR 2.1 vector with NotI.  The 27zn ZmHb nos vector 
was digested with NotI, and the vector ligated with the Zntm product forming vector 
27zn ZmHb Zntm.  Prior to stable transformation into maize callus, the 27zn ZmHb Zntm 
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vector was linearized to remove non-maize genetic material, thereby having an intragenic 
transformation event.  This construct is ready for transformation. 
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Figure 5.5. Schematic drawings of constructs developed for future work in 
overexpression of Zea mays hemoglobin in maize endosperm.  A – 27zn ZmHb nos, B – 
27zn ZmHb Znterm.   
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General Conclusions 
 
Summary 
 As shown in the three studies of this dissertation, through novel methods of 
fortification, processing and biotechnology the bioavailability of maize can be increased 
significantly over the typical fortification or processing methods, or over the common 
inbred lines of maize.  Improvements in iron bioavailability are possible, and could, in 
the case of the processing technologies, be applied immediately.   
 
Recommendations and Future Research 
 The research studies presented have various levels of feasibility and practicality in 
the real world.  The use of soybean leghemoglobin as a fortificant, while interesting, and 
potentially a high value added component for soy production, is highly inefficient at this 
point, and not cost effective in contrast to the standard fortificants.  The soy 
leghemoglobin study is most useful as a proof of concept study, showing that plants 
indeed produce hemoglobin, and the hemoglobin is comparable to animal sourced 
hemoglobin in iron nutrition.  As such, this proof of concept lends itself very well to the 
biotechnology based project, in that evidence was there showing that plant hemoglobin is 
bioavalable, prior to engaging in a long term plant transformation project.   
 The research presented in the fermentation and lactic acid enhancement paper is 
the most feasible research for immediate application.  With a second human study, either 
a bioavailability or efficacy trial, evaluating the effect of lactic acid enhanced tortillas or 
arepas on iron status, this could have a strong effect on encouraging process 
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modification.  Further research into maize product quality when enhanced with lactic 
acid, be it organoleptic, microbial, and process quality would be required.  Acceptability 
within the consuming populations, both by processors (industrial and community scale) 
as well as by the consumers would also need to be evaluated. 
 With the development of hemoglobin expression in maize, a long term breeding 
program must be developed to select for highest expression of ZmHb.  As alluded to in 
the appendix of Part 5, two further constructs have been developed for stable 
transformation, including one construct comprised of only maize coding sequences.  The 
intention of this project in the long term is to develop intragenic transformations 
overexpressing maize hemoglobin.  As such it would bring an entirely novel approach to 
biofortification in maize.  Studies into evaluating the phenotype of the transformed maize 
would be of considerable interest, as would proteomic or transcriptomic studies to better 
characterize how heme synthesis or iron uptake pathways are being modified in the 
transformed maize.  Once characterized, it could be better determined if a second 
transformation would be necessary to upregulate iron uptake, or incorporation into the 
protein.  Lastly characterizing the processing stability of the hemoglobin enhanced maize 
would be vital to its application.   
One consideration with the different strategies presented is whether there could be 
a synergistic effect of combining technologies, for example processing the biotechnology 
enhanced maize with lactic acid, or fermentation to achieve yet higher bioavailability.   
Given the diversity of maize food products, and the diversity of consumers, the 
strongest approach to enhancing iron bioavailability in maize is a diversified approach.  
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With novel strategies, combined with the existing knowledge and technologies, a greater 
impact on decreasing iron deficiency could be realized.   
